| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | actin binding | MYH1 MYH4 MYH8 XIRP1 MYH10 MYH13 MYO5A MYH7B SYNE1 FMNL2 JMY IQGAP1 MICAL2 SYNE2 MYPN MACF1 DIAPH3 DMD SETD3 CAP2 | 3.34e-09 | 479 | 166 | 20 | GO:0003779 |
| GeneOntologyMolecularFunction | microfilament motor activity | 2.46e-08 | 38 | 166 | 7 | GO:0000146 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH1 MYH4 MYH8 XIRP1 MYH10 MYH13 ANK3 MYO5A CENPF MYH7B SYNE1 IFT81 FMNL2 CLIP1 JMY IQGAP1 S100A6 KIF2B MICAL2 PDCD5 SYNE2 MYPN CCSER2 CEP70 MACF1 DIAPH3 DMD SETD3 CAP2 | 2.95e-08 | 1099 | 166 | 29 | GO:0008092 |
| GeneOntologyMolecularFunction | actin filament binding | MYH1 MYH4 MYH8 XIRP1 MYH10 MYH13 MYO5A MYH7B SYNE1 FMNL2 IQGAP1 MACF1 | 4.55e-07 | 227 | 166 | 12 | GO:0051015 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 6.29e-07 | 118 | 166 | 9 | GO:0003774 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH1 MYH4 MYH8 MYH10 DDX49 MYH13 MYO5A ABCA13 MYH7B CHD9 ATP8B1 ACSS2 DNAH1 KIF2B MACF1 ATP2B2 TOP2A TOP2B SMC1B | 8.96e-07 | 614 | 166 | 19 | GO:0140657 |
| GeneOntologyMolecularFunction | calmodulin binding | MYH1 MYH4 MYH8 MYH10 MYH13 MYO5A IQGAP1 EEA1 ATP2B2 PCNT IQCG | 3.67e-06 | 230 | 166 | 11 | GO:0005516 |
| GeneOntologyMolecularFunction | DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity | 4.08e-04 | 4 | 166 | 2 | GO:0003918 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 6.76e-04 | 5 | 166 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 7.16e-04 | 231 | 166 | 8 | GO:0005085 | |
| GeneOntologyBiologicalProcess | cilium organization | GBF1 SYNE1 TTC39C RAB8B IFT81 LCA5L ODAD4 DZIP1 BBS9 DNAH1 EHD2 TBC1D32 WDR11 CEP89 CFAP97D1 TTC29 SYNE2 CEP70 CFAP57 SCLT1 PCNT IQCG | 2.81e-11 | 476 | 163 | 22 | GO:0044782 |
| GeneOntologyBiologicalProcess | cilium assembly | GBF1 SYNE1 TTC39C RAB8B IFT81 ODAD4 DZIP1 BBS9 DNAH1 EHD2 TBC1D32 WDR11 CEP89 CFAP97D1 SYNE2 CEP70 CFAP57 SCLT1 PCNT IQCG | 3.77e-10 | 444 | 163 | 20 | GO:0060271 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | MYH10 GBF1 SYNE1 TTC39C RAB8B IFT81 ODAD4 ATP8B1 DZIP1 BBS9 DNAH1 EHD2 TBC1D32 WDR11 CEP89 CFAP97D1 SYNE2 CEP70 CFAP57 SCLT1 PCNT IQCG | 1.64e-08 | 670 | 163 | 22 | GO:0120031 |
| GeneOntologyBiologicalProcess | cell projection assembly | MYH10 GBF1 SYNE1 TTC39C RAB8B IFT81 ODAD4 ATP8B1 DZIP1 BBS9 DNAH1 EHD2 TBC1D32 WDR11 CEP89 CFAP97D1 SYNE2 CEP70 CFAP57 SCLT1 PCNT IQCG | 2.43e-08 | 685 | 163 | 22 | GO:0030031 |
| GeneOntologyBiologicalProcess | organelle assembly | XIRP1 MYH10 GBF1 CENPF SYNE1 TTC39C RAB8B IFT81 RAB1C ODAD4 DZIP1 BBS9 DNAH1 EHD2 TBC1D32 CHMP4A WDR11 CEP89 CFAP97D1 SYNE2 MYPN CEP70 SASS6 DIAPH3 CFAP57 SCLT1 PCNT IQCG | 7.81e-08 | 1138 | 163 | 28 | GO:0070925 |
| GeneOntologyBiologicalProcess | microtubule-based process | ANK3 MYO5A IFT81 SPC25 LCA5L ODAD4 CHEK1 DZIP1 CLIP1 DNAH1 TBC1D32 CHMP4A AKAP9 KIF2B CFAP97D1 TTC29 SYNE2 CCSER2 CEP70 SASS6 MACF1 DIAPH3 CFAP57 PCNT IQCG | 8.97e-07 | 1058 | 163 | 25 | GO:0007017 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | ANK3 SPC25 ODAD4 CHEK1 DZIP1 CLIP1 DNAH1 TBC1D32 CHMP4A AKAP9 KIF2B CFAP97D1 SYNE2 CCSER2 CEP70 SASS6 DIAPH3 CFAP57 PCNT IQCG | 1.10e-06 | 720 | 163 | 20 | GO:0000226 |
| GeneOntologyBiologicalProcess | sperm flagellum assembly | 5.20e-06 | 56 | 163 | 6 | GO:0120316 | |
| GeneOntologyBiologicalProcess | actin filament-based process | NPHP1 MYH4 MYH8 XIRP1 MYH10 MYO5A MYH7B IQSEC2 FMNL2 JMY IQGAP1 EHD2 AKAP9 MICAL2 SYNE2 MYPN DIAPH3 ARHGAP18 SETD3 RAB13 CAP2 | 1.09e-05 | 912 | 163 | 21 | GO:0030029 |
| GeneOntologyBiologicalProcess | microtubule bundle formation | 2.04e-05 | 145 | 163 | 8 | GO:0001578 | |
| GeneOntologyBiologicalProcess | positive regulation of single stranded viral RNA replication via double stranded DNA intermediate | 6.21e-05 | 2 | 163 | 2 | GO:0045870 | |
| GeneOntologyBiologicalProcess | motile cilium assembly | 7.05e-05 | 88 | 163 | 6 | GO:0044458 | |
| GeneOntologyBiologicalProcess | intracellular transport | IPO5 MYH10 GBF1 ANK3 COPA UACA MYO5A CCDC186 SYNE1 RAB8B IFT81 RAB1C LCA5L CLIP1 STAR EHD2 CHMP4A WDR11 CD36 PDCD5 SYNE2 DIAPH3 EEA1 HEATR5B RAB13 PCNT | 1.18e-04 | 1496 | 163 | 26 | GO:0046907 |
| GeneOntologyBiologicalProcess | microtubule-based movement | ANK3 MYO5A IFT81 LCA5L ODAD4 DZIP1 DNAH1 KIF2B CFAP97D1 TTC29 SYNE2 CFAP57 IQCG | 1.54e-04 | 493 | 163 | 13 | GO:0007018 |
| GeneOntologyBiologicalProcess | actin filament-based movement | 2.18e-04 | 153 | 163 | 7 | GO:0030048 | |
| GeneOntologyBiologicalProcess | axoneme assembly | 2.30e-04 | 109 | 163 | 6 | GO:0035082 | |
| GeneOntologyCellularComponent | myosin filament | 3.33e-08 | 25 | 164 | 6 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 6.95e-08 | 28 | 164 | 6 | GO:0016460 | |
| GeneOntologyCellularComponent | myosin complex | 3.90e-07 | 59 | 164 | 7 | GO:0016459 | |
| GeneOntologyCellularComponent | ciliary transition fiber | 7.39e-07 | 10 | 164 | 4 | GO:0097539 | |
| GeneOntologyCellularComponent | supramolecular fiber | MYH1 MYH4 MYH8 MYH10 MYH13 ANK3 MYO5A MYH7B SYNE1 CLIP1 BFSP1 IQGAP1 DNAH1 EFHC2 CHMP4A CFAP77 KIF2B MICAL2 SYNE2 MYPN MACF1 DIAPH3 DMD ARHGAP18 PCNT | 5.45e-06 | 1179 | 164 | 25 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MYH1 MYH4 MYH8 MYH10 MYH13 ANK3 MYO5A MYH7B SYNE1 CLIP1 BFSP1 IQGAP1 DNAH1 EFHC2 CHMP4A CFAP77 KIF2B MICAL2 SYNE2 MYPN MACF1 DIAPH3 DMD ARHGAP18 PCNT | 6.13e-06 | 1187 | 164 | 25 | GO:0099081 |
| GeneOntologyCellularComponent | muscle myosin complex | 6.18e-06 | 16 | 164 | 4 | GO:0005859 | |
| GeneOntologyCellularComponent | cilium | NPHP1 MYO5A CENPF IFT81 LCA5L ODAD4 DZIP1 BBS9 DNAH1 EFHC2 TBC1D32 AKAP9 CFAP77 WDR11 CEP89 TTC29 CFAP57 SCLT1 ATP2B2 PCNT IQCG | 7.73e-06 | 898 | 164 | 21 | GO:0005929 |
| GeneOntologyCellularComponent | cell leading edge | MYH10 GBF1 MYO5A CLIP1 JMY IQGAP1 S100A6 BMX SYNE2 MACF1 DMD ARHGAP18 ATP2B2 RAB13 | 4.18e-05 | 500 | 164 | 14 | GO:0031252 |
| GeneOntologyCellularComponent | myofibril | 6.15e-05 | 273 | 164 | 10 | GO:0030016 | |
| GeneOntologyCellularComponent | chromosome, centromeric region | CENPF SPC25 CLIP1 SYCP2 NCAPG CHMP4A WDHD1 KIF2B TOP2A SMC1B | 6.74e-05 | 276 | 164 | 10 | GO:0000775 |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.01e-04 | 290 | 164 | 10 | GO:0043292 | |
| GeneOntologyCellularComponent | ciliary basal body | 1.57e-04 | 195 | 164 | 8 | GO:0036064 | |
| GeneOntologyCellularComponent | condensed chromosome | CENPF SPC25 CHEK1 CLIP1 SYCP2 NCAPG CHMP4A KIF2B TOP2A SMC1B | 1.61e-04 | 307 | 164 | 10 | GO:0000793 |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH1 MYH4 MYH8 XIRP1 MYH10 MYH13 MYO5A KALRN MYH7B IQGAP1 MICAL2 MACF1 DIAPH3 IQCG | 1.86e-04 | 576 | 164 | 14 | GO:0015629 |
| GeneOntologyCellularComponent | microtubule organizing center | CENPF IFT81 CHEK1 DZIP1 BBS9 CLIP1 EFHC2 AKAP9 KIF2B WDR11 CEP89 CAPRIN2 CEP70 SASS6 DIAPH3 SCLT1 TOP2A PCNT | 3.31e-04 | 919 | 164 | 18 | GO:0005815 |
| GeneOntologyCellularComponent | centriole | 4.26e-04 | 172 | 164 | 7 | GO:0005814 | |
| GeneOntologyCellularComponent | chromosomal region | CENPF SPC25 CHEK1 CLIP1 SYCP2 NCAPG CHMP4A WDHD1 KIF2B TOP2A SMC1B | 5.07e-04 | 421 | 164 | 11 | GO:0098687 |
| GeneOntologyCellularComponent | motile cilium | 5.11e-04 | 355 | 164 | 10 | GO:0031514 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | STAB2 COPA ABCA13 RAB8B TOM1L1 ZDHHC17 RAB11FIP1 CLIP1 IQGAP1 TFRC EHD2 ARFGEF3 CHMP4A CD36 DIAPH3 EEA1 DMD SLC39A14 PRAF2 RAB13 SERPINA5 SH3BP5 | 5.81e-04 | 1307 | 164 | 22 | GO:0030659 |
| GeneOntologyCellularComponent | RNA polymerase transcription factor SL1 complex | 6.02e-04 | 5 | 164 | 2 | GO:0005668 | |
| GeneOntologyCellularComponent | vesicle membrane | STAB2 COPA ABCA13 RAB8B TOM1L1 ZDHHC17 RAB11FIP1 CLIP1 IQGAP1 TFRC EHD2 ARFGEF3 CHMP4A CD36 DIAPH3 EEA1 DMD SLC39A14 PRAF2 RAB13 SERPINA5 SH3BP5 | 6.97e-04 | 1325 | 164 | 22 | GO:0012506 |
| GeneOntologyCellularComponent | lateral plasma membrane | 7.18e-04 | 90 | 164 | 5 | GO:0016328 | |
| GeneOntologyCellularComponent | sarcomere | 8.02e-04 | 249 | 164 | 8 | GO:0030017 | |
| GeneOntologyCellularComponent | condensed chromosome, centromeric region | 8.43e-04 | 193 | 164 | 7 | GO:0000779 | |
| GeneOntologyCellularComponent | RNA polymerase I transcription regulator complex | 8.99e-04 | 6 | 164 | 2 | GO:0000120 | |
| GeneOntologyCellularComponent | nuclear chromosome | 9.12e-04 | 254 | 164 | 8 | GO:0000228 | |
| GeneOntologyCellularComponent | ruffle | 1.23e-03 | 206 | 164 | 7 | GO:0001726 | |
| GeneOntologyCellularComponent | axoneme | 1.27e-03 | 207 | 164 | 7 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 1.30e-03 | 208 | 164 | 7 | GO:0097014 | |
| GeneOntologyCellularComponent | pericentriolar material | 1.34e-03 | 28 | 164 | 3 | GO:0000242 | |
| GeneOntologyCellularComponent | recycling endosome | 1.89e-03 | 222 | 164 | 7 | GO:0055037 | |
| GeneOntologyCellularComponent | ribbon synapse | 1.99e-03 | 32 | 164 | 3 | GO:0097470 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 2.79e-03 | 238 | 164 | 7 | GO:0097729 | |
| GeneOntologyCellularComponent | centrosome | CENPF IFT81 CHEK1 DZIP1 BBS9 CLIP1 AKAP9 KIF2B CEP89 CAPRIN2 CEP70 SASS6 SCLT1 PCNT | 3.05e-03 | 770 | 164 | 14 | GO:0005813 |
| GeneOntologyCellularComponent | nuclear membrane protein complex | 3.21e-03 | 11 | 164 | 2 | GO:0106083 | |
| GeneOntologyCellularComponent | nuclear membrane microtubule tethering complex | 3.21e-03 | 11 | 164 | 2 | GO:0106094 | |
| GeneOntologyCellularComponent | microtubule organizing center attachment site | 3.21e-03 | 11 | 164 | 2 | GO:0034992 | |
| GeneOntologyCellularComponent | meiotic nuclear membrane microtubule tethering complex | 3.21e-03 | 11 | 164 | 2 | GO:0034993 | |
| GeneOntologyCellularComponent | insulin-responsive compartment | 3.21e-03 | 11 | 164 | 2 | GO:0032593 | |
| HumanPheno | Juvenile onset | NPHP1 ATP8B1 THAP1 ERLIN1 BFSP1 POLR3A ERLIN2 AKAP9 WDR11 SYNE2 MYPN GAN MACF1 LTBP2 DIAPH3 DMD SLC39A14 ATP2B2 CAP2 | 2.13e-05 | 700 | 51 | 19 | HP:0003621 |
| HumanPheno | Tip-toe gait | 2.81e-05 | 91 | 51 | 7 | HP:0030051 | |
| Domain | Myosin-like_IQ_dom | 1.70e-10 | 19 | 165 | 7 | IPR027401 | |
| Domain | - | 1.70e-10 | 19 | 165 | 7 | 4.10.270.10 | |
| Domain | IQ_motif_EF-hand-BS | MYH1 MYH4 MYH8 MYH10 MYH13 RASGRF1 MYO5A MYH7B IQSEC2 IQGAP1 IQCG | 4.17e-10 | 90 | 165 | 11 | IPR000048 |
| Domain | IQ | MYH1 MYH4 MYH8 MYH10 MYH13 RASGRF1 MYO5A MYH7B IQSEC2 IQGAP1 IQCG | 5.97e-10 | 93 | 165 | 11 | PS50096 |
| Domain | IQ | 6.39e-10 | 71 | 165 | 10 | PF00612 | |
| Domain | Myosin_N | 2.03e-09 | 15 | 165 | 6 | PF02736 | |
| Domain | Myosin_N | 2.03e-09 | 15 | 165 | 6 | IPR004009 | |
| Domain | IQ | 2.41e-09 | 81 | 165 | 10 | SM00015 | |
| Domain | Myosin_tail_1 | 7.38e-09 | 18 | 165 | 6 | PF01576 | |
| Domain | Myosin_tail | 7.38e-09 | 18 | 165 | 6 | IPR002928 | |
| Domain | Myosin_head_motor_dom | 3.71e-08 | 38 | 165 | 7 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 3.71e-08 | 38 | 165 | 7 | PS51456 | |
| Domain | Myosin_head | 3.71e-08 | 38 | 165 | 7 | PF00063 | |
| Domain | MYSc | 3.71e-08 | 38 | 165 | 7 | SM00242 | |
| Domain | Spectrin_repeat | 1.74e-07 | 29 | 165 | 6 | IPR002017 | |
| Domain | SPEC | 3.25e-07 | 32 | 165 | 6 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 3.25e-07 | 32 | 165 | 6 | IPR018159 | |
| Domain | Spectrin | 1.50e-06 | 23 | 165 | 5 | PF00435 | |
| Domain | CH | 1.67e-06 | 65 | 165 | 7 | SM00033 | |
| Domain | CH | 2.78e-06 | 70 | 165 | 7 | PF00307 | |
| Domain | - | 3.06e-06 | 71 | 165 | 7 | 1.10.418.10 | |
| Domain | CH | 3.69e-06 | 73 | 165 | 7 | PS50021 | |
| Domain | CH-domain | 4.43e-06 | 75 | 165 | 7 | IPR001715 | |
| Domain | ACTININ_2 | 4.56e-05 | 23 | 165 | 4 | PS00020 | |
| Domain | ACTININ_1 | 4.56e-05 | 23 | 165 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 4.56e-05 | 23 | 165 | 4 | IPR001589 | |
| Domain | - | 7.76e-05 | 2 | 165 | 2 | 3.40.50.670 | |
| Domain | DTHCT | 7.76e-05 | 2 | 165 | 2 | IPR012542 | |
| Domain | DNA_gyraseB | 7.76e-05 | 2 | 165 | 2 | PF00204 | |
| Domain | PACT_coil_coil | 7.76e-05 | 2 | 165 | 2 | PF10495 | |
| Domain | - | 7.76e-05 | 2 | 165 | 2 | 3.90.199.10 | |
| Domain | TopoIIA_CS | 7.76e-05 | 2 | 165 | 2 | IPR018522 | |
| Domain | Topo_IIA | 7.76e-05 | 2 | 165 | 2 | IPR001241 | |
| Domain | Erlin1/2 | 7.76e-05 | 2 | 165 | 2 | IPR033294 | |
| Domain | DNA_topoisoIV | 7.76e-05 | 2 | 165 | 2 | PF00521 | |
| Domain | Topo_IIA_A/C_ab | 7.76e-05 | 2 | 165 | 2 | IPR013758 | |
| Domain | Topo_IIA_A_a | 7.76e-05 | 2 | 165 | 2 | IPR013757 | |
| Domain | Topo_IIA_cen_dom | 7.76e-05 | 2 | 165 | 2 | IPR013759 | |
| Domain | TOP4c | 7.76e-05 | 2 | 165 | 2 | SM00434 | |
| Domain | TOP2c | 7.76e-05 | 2 | 165 | 2 | SM00433 | |
| Domain | Topo_IIA-like_dom | 7.76e-05 | 2 | 165 | 2 | IPR013760 | |
| Domain | Topo_IIA_bsu_dom2 | 7.76e-05 | 2 | 165 | 2 | IPR013506 | |
| Domain | DTHCT | 7.76e-05 | 2 | 165 | 2 | PF08070 | |
| Domain | KIAA1430 | 7.76e-05 | 2 | 165 | 2 | PF13879 | |
| Domain | - | 7.76e-05 | 2 | 165 | 2 | 1.10.268.10 | |
| Domain | Hmw/KIAA1430 | 7.76e-05 | 2 | 165 | 2 | IPR029488 | |
| Domain | TOPRIM_C | 7.76e-05 | 2 | 165 | 2 | IPR031660 | |
| Domain | TOPRIM_C | 7.76e-05 | 2 | 165 | 2 | PF16898 | |
| Domain | PACT_domain | 7.76e-05 | 2 | 165 | 2 | IPR019528 | |
| Domain | Topo_IIA_A/C | 7.76e-05 | 2 | 165 | 2 | IPR002205 | |
| Domain | TOPOISOMERASE_II | 7.76e-05 | 2 | 165 | 2 | PS00177 | |
| Domain | P-loop_NTPase | MTG1 MYH1 MYH4 MYH8 MYH10 DDX49 MYH13 MYO5A ABCA13 MYH7B RAB8B CHD9 IQGAP1 DNAH1 EHD2 KIF2B MTIF2 RAB13 SMC1B | 1.83e-04 | 848 | 165 | 19 | IPR027417 |
| Domain | Arg_repress_C-like | 2.31e-04 | 3 | 165 | 2 | IPR024946 | |
| Domain | - | 2.31e-04 | 3 | 165 | 2 | 3.30.1360.40 | |
| Domain | SEC7 | 3.48e-04 | 16 | 165 | 3 | PS50190 | |
| Domain | Sec7 | 3.48e-04 | 16 | 165 | 3 | SM00222 | |
| Domain | Sec7_dom | 3.48e-04 | 16 | 165 | 3 | IPR000904 | |
| Domain | KASH | 4.60e-04 | 4 | 165 | 2 | IPR012315 | |
| Domain | KASH | 4.60e-04 | 4 | 165 | 2 | PS51049 | |
| Domain | Toprim | 4.60e-04 | 4 | 165 | 2 | PF01751 | |
| Domain | KASH | 4.60e-04 | 4 | 165 | 2 | SM01249 | |
| Domain | KASH | 4.60e-04 | 4 | 165 | 2 | PF10541 | |
| Domain | Toprim_domain | 4.60e-04 | 4 | 165 | 2 | IPR006171 | |
| Domain | TOPRIM | 4.60e-04 | 4 | 165 | 2 | PS50880 | |
| Domain | Apc4_WD40_dom | 6.91e-04 | 20 | 165 | 3 | IPR024977 | |
| Domain | ANAPC4_WD40 | 6.91e-04 | 20 | 165 | 3 | PF12894 | |
| Domain | Myosin_S1_N | 7.62e-04 | 5 | 165 | 2 | IPR008989 | |
| Domain | TIF_beta_prop-like | 7.62e-04 | 5 | 165 | 2 | IPR013979 | |
| Domain | eIF2A | 7.62e-04 | 5 | 165 | 2 | PF08662 | |
| Domain | ITI_HC_C | 1.14e-03 | 6 | 165 | 2 | IPR010600 | |
| Domain | ITI_HC_C | 1.14e-03 | 6 | 165 | 2 | PF06668 | |
| Domain | SH2 | 2.03e-03 | 101 | 165 | 5 | PF00017 | |
| Domain | DAD_dom | 2.10e-03 | 8 | 165 | 2 | IPR014767 | |
| Domain | DAD | 2.10e-03 | 8 | 165 | 2 | PS51231 | |
| Domain | VIT | 2.10e-03 | 8 | 165 | 2 | PF08487 | |
| Domain | VIT | 2.10e-03 | 8 | 165 | 2 | SM00609 | |
| Domain | DH_1 | 2.33e-03 | 63 | 165 | 4 | PS00741 | |
| Domain | BTK | 2.68e-03 | 9 | 165 | 2 | SM00107 | |
| Domain | Drf_GBD | 2.68e-03 | 9 | 165 | 2 | PF06371 | |
| Domain | Drf_FH3 | 2.68e-03 | 9 | 165 | 2 | PF06367 | |
| Domain | Znf_Btk_motif | 2.68e-03 | 9 | 165 | 2 | IPR001562 | |
| Domain | FH3_dom | 2.68e-03 | 9 | 165 | 2 | IPR010472 | |
| Domain | GTPase-bd | 2.68e-03 | 9 | 165 | 2 | IPR010473 | |
| Domain | BTK | 2.68e-03 | 9 | 165 | 2 | PF00779 | |
| Domain | ZF_BTK | 2.68e-03 | 9 | 165 | 2 | PS51113 | |
| Domain | Drf_FH3 | 2.68e-03 | 9 | 165 | 2 | SM01139 | |
| Domain | Drf_GBD | 2.68e-03 | 9 | 165 | 2 | SM01140 | |
| Domain | - | 2.88e-03 | 333 | 165 | 9 | 2.130.10.10 | |
| Domain | SH2 | 2.94e-03 | 110 | 165 | 5 | SM00252 | |
| Domain | WD40/YVTN_repeat-like_dom | 3.00e-03 | 335 | 165 | 9 | IPR015943 | |
| Domain | SH2 | 3.06e-03 | 111 | 165 | 5 | PS50001 | |
| Domain | RhoGEF | 3.08e-03 | 68 | 165 | 4 | SM00325 | |
| Domain | SH2 | 3.18e-03 | 112 | 165 | 5 | IPR000980 | |
| Domain | - | 3.18e-03 | 112 | 165 | 5 | 3.30.505.10 | |
| Domain | VIT | 3.33e-03 | 10 | 165 | 2 | PS51468 | |
| Domain | VIT | 3.33e-03 | 10 | 165 | 2 | IPR013694 | |
| Domain | WD_REPEATS_1 | 3.35e-03 | 278 | 165 | 8 | PS00678 | |
| Domain | RhoGEF | 3.42e-03 | 70 | 165 | 4 | PF00621 | |
| Domain | DH_2 | 3.42e-03 | 70 | 165 | 4 | PS50010 | |
| Domain | WD_REPEATS_2 | 3.42e-03 | 279 | 165 | 8 | PS50082 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 2.90e-06 | 70 | 126 | 7 | M12294 | |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 3.72e-05 | 70 | 126 | 6 | MM15597 | |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 5.10e-05 | 74 | 126 | 6 | M41807 | |
| Pathway | REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE | NPHP1 GBF1 IFT81 CHD9 ACSS2 BBS9 AKAP9 CEP89 CEP70 SCLT1 PCNT | 7.15e-05 | 297 | 126 | 11 | M27050 |
| Pathway | REACTOME_CILIUM_ASSEMBLY | 7.96e-05 | 201 | 126 | 9 | M27472 | |
| Pathway | REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE | 1.43e-04 | 217 | 126 | 9 | MM14708 | |
| Pathway | KEGG_TIGHT_JUNCTION | 1.80e-04 | 132 | 126 | 7 | M11355 | |
| Pathway | REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE | 2.30e-04 | 97 | 126 | 6 | M27478 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 2.83e-04 | 142 | 126 | 7 | MM15576 | |
| Pathway | REACTOME_RHOH_GTPASE_CYCLE | 3.20e-04 | 37 | 126 | 4 | M41813 | |
| Pathway | PID_RAC1_REG_PATHWAY | 3.55e-04 | 38 | 126 | 4 | M241 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 3.79e-04 | 149 | 126 | 7 | M41805 | |
| Pathway | REACTOME_RHOG_GTPASE_CYCLE | 4.28e-04 | 71 | 126 | 5 | MM15604 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 4.90e-04 | 204 | 126 | 8 | M4217 | |
| Pathway | REACTOME_RHOG_GTPASE_CYCLE | 5.18e-04 | 74 | 126 | 5 | M41814 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | MYH10 KALRN CENPF SPC25 MCF2 FMNL2 CLIP1 ZAP70 IQGAP1 TFRC KIF2B WDR11 DIAPH3 ARHGAP18 VAV1 | 6.75e-04 | 649 | 126 | 15 | MM15690 |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | MYH10 UACA KALRN CENPF SPC25 MCF2 FMNL2 CLIP1 ZAP70 IQGAP1 TFRC KIF2B WDR11 DIAPH3 ARHGAP18 VAV1 | 6.79e-04 | 720 | 126 | 16 | M41838 |
| Pubmed | MYH1 MYH4 MACC1 MYH8 MYH10 MYH13 COPA MYO5A CENPF MYH7B SYNE1 RAB8B IFT81 UGGT1 ZNF318 RPL14 ZDHHC17 ERLIN1 TASOR2 IQGAP1 TFRC ERLIN2 SND1 CEBPZ SYNE2 CAPRIN2 MACF1 TNFAIP8 DIAPH3 EEA1 DMD ATP2B2 TOP2A TOP2B PCNT | 2.66e-15 | 1442 | 169 | 35 | 35575683 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | IPO5 COPA MYO5A CENPF SYNE1 UGGT1 ZNF318 RPL14 ERLIN1 IQGAP1 TFRC RBM25 SND1 CEBPZ SYNE2 PDCD11 MACF1 PRKCSH EIF3B EEA1 HEATR5B TOP2A TOP2B PCNT | 2.05e-10 | 1024 | 169 | 24 | 24711643 |
| Pubmed | CASP8AP2 ANK3 UACA MYO5A SYNE1 IFT81 UGGT1 RPL14 DZIP1 ZDHHC17 RAB11FIP1 TMCC3 TFRC NCAPG AKAP9 SND1 WDR11 CEP89 CEBPZ MTIF2 SYNE2 CCSER2 PDCD11 MACF1 PRKCSH DIAPH3 TOP2B PCNT | 7.96e-10 | 1487 | 169 | 28 | 33957083 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | IPO5 MTG1 MYH10 COPA CENPF SYNE1 RPL14 CHEK1 ZDHHC17 TMCC3 ERLIN1 POLR3A ARFGEF3 ERLIN2 AKAP9 MRPL14 SND1 MTIF2 PDCD5 SYNE2 PDCD11 SASS6 PRKCSH DIAPH3 SLC39A14 RAB13 TOP2A PCNT | 9.10e-10 | 1496 | 169 | 28 | 32877691 |
| Pubmed | IPO5 MYH10 COPA MYO5A CENPF UGGT1 GEMIN5 ZNF318 RPL14 TASOR2 IQGAP1 RBM25 SND1 CEBPZ SYNE2 PDCD11 MACF1 PCNT | 3.71e-09 | 653 | 169 | 18 | 22586326 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | IPO5 MYH4 MYH10 GBF1 COPA UACA MYO5A UGGT1 GEMIN5 IQGAP1 TOP2B | 5.01e-09 | 202 | 169 | 11 | 33005030 |
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 8.01e-09 | 6 | 169 | 4 | 10077619 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | IPO5 MYH10 ANK3 COPA SYNE1 UGGT1 RPL14 IQGAP1 DNAH1 TFRC S100A6 ERLIN2 AKAP9 SND1 MACF1 PRKCSH EIF3B EEA1 ARHGAP18 | 1.69e-08 | 807 | 169 | 19 | 30575818 |
| Pubmed | IPO5 ANK3 COPA MYO5A KALRN SYNE1 IFT81 TAF1C IQSEC2 CHD9 DZIP1 REV3L FMNL2 BFSP1 IQGAP1 MICAL2 HECTD2 MTIF2 CEP70 MACF1 RSBN1L CAP2 SH3BP5 PCNT | 1.73e-08 | 1285 | 169 | 24 | 35914814 | |
| Pubmed | 1.86e-08 | 7 | 169 | 4 | 35210422 | ||
| Pubmed | IPO5 MYH10 COPA UACA UGGT1 GEMIN5 RPL14 JMY ERLIN1 POLR3A IQGAP1 TFRC EHD2 ARFGEF3 S100A6 NCAPG ERLIN2 SND1 CEBPZ SYNE2 PDCD11 EIF3B SLC39A14 TOP2A TOP2B | 3.50e-08 | 1440 | 169 | 25 | 30833792 | |
| Pubmed | GBF1 ANK3 CCDC186 TMCC3 POLR3A ARFGEF3 CEP89 SYNE2 CCSER2 EIF3B DOT1L | 4.70e-08 | 251 | 169 | 11 | 29778605 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | IPO5 DDX49 COPA UACA CENPF SYNE1 SPC25 CHEK1 CLIP1 TASOR2 IQGAP1 TFRC PDCD5 MYPN CCSER2 SASS6 PRKCSH EIF3B EEA1 TOP2A CFAP97 TOP2B | 5.12e-08 | 1155 | 169 | 22 | 20360068 |
| Pubmed | 5.96e-08 | 151 | 169 | 9 | 17043677 | ||
| Pubmed | MYH10 COPA MYO5A UGGT1 ERLIN1 TFRC ERLIN2 SND1 MACF1 EEA1 TOP2A TOP2B | 7.95e-08 | 327 | 169 | 12 | 31409639 | |
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 36515178 | ||
| Pubmed | IPO5 CASP8AP2 COPA GEMIN5 CHD9 ACSS2 POLR3A IQGAP1 TFRC EHD2 S100A6 RBM25 NCAPG WDHD1 SND1 PDCD5 EIF3B SAP130 TOP2A TOP2B | 1.25e-07 | 1014 | 169 | 20 | 32416067 | |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 1.39e-07 | 120 | 169 | 8 | 31413325 | |
| Pubmed | IPO5 MYH10 COPA CENPF UGGT1 GEMIN5 CHD9 RPL14 CLIP1 IQGAP1 TFRC SND1 PRKCSH EIF3B | 1.56e-07 | 494 | 169 | 14 | 26831064 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYH10 DDX49 COPA MYO5A TAF1C GEMIN5 RPL14 ERLIN1 POLR3A IQGAP1 TFRC NCAPG MRPL14 SND1 WDR11 CEBPZ MICAL2 PDCD11 MACF1 EIF3B RAB13 TOP2A TOP2B | 1.90e-07 | 1353 | 169 | 23 | 29467282 |
| Pubmed | MYH10 ANK3 UACA MYO5A KALRN CENPF SYNE1 IQSEC2 ZNF318 CLIP1 ITIH1 IQGAP1 AKAP9 SYNE2 MACF1 PRAF2 CAP2 SH3BP5 PCNT | 2.63e-07 | 963 | 169 | 19 | 28671696 | |
| Pubmed | 4.49e-07 | 4 | 169 | 3 | 1985022 | ||
| Pubmed | 4.49e-07 | 4 | 169 | 3 | 10388558 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | IPO5 MYH10 GBF1 COPA CENPF SYNE1 UGGT1 GEMIN5 RPL14 POLR3A IQGAP1 TFRC RBM25 NCAPG ERLIN2 SND1 CEBPZ PDCD11 PRKCSH EIF3B EEA1 TOP2A TOP2B | 4.69e-07 | 1425 | 169 | 23 | 30948266 |
| Pubmed | ANK3 GEMIN5 ZNF318 RBM25 NCAPG SND1 CEBPZ PDCD5 PDCD11 DIAPH3 DOT1L SAP130 TOP2A RSBN1L | 5.54e-07 | 549 | 169 | 14 | 38280479 | |
| Pubmed | IPO5 MYH10 COPA RPL14 IQGAP1 TFRC NCAPG SND1 PDCD11 EIF3B SLC39A14 TOP2A TOP2B | 8.02e-07 | 484 | 169 | 13 | 31995728 | |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 8.51e-07 | 268 | 169 | 10 | 33024031 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | MYH10 MYH13 COPA GEMIN5 RPL14 CLIP1 ERLIN1 POLR3A RBM25 NCAPG ERLIN2 PDCD5 MACF1 PRKCSH EIF3B EEA1 PCNT | 9.23e-07 | 847 | 169 | 17 | 35235311 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | IPO5 MYH10 COPA UACA MYO5A SYNE1 RAB8B RAB1C RPL14 IQGAP1 RBM25 MRPL14 SND1 CEBPZ PDCD11 EIF3B RAB13 TOP2A | 9.73e-07 | 949 | 169 | 18 | 36574265 |
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 1.12e-06 | 5 | 169 | 3 | 3829126 | |
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 1.12e-06 | 5 | 169 | 3 | 12919077 | |
| Pubmed | 1.12e-06 | 5 | 169 | 3 | 6196357 | ||
| Pubmed | IPO5 MYH10 COPA UGGT1 GEMIN5 RPL14 RAB11FIP1 ERLIN1 TFRC S100A6 ERLIN2 SND1 PDCD5 SYNE2 PDCD11 MACF1 PRKCSH DIAPH3 EEA1 SLC39A14 RAB13 | 1.47e-06 | 1297 | 169 | 21 | 33545068 | |
| Pubmed | 2.23e-06 | 6 | 169 | 3 | 1728586 | ||
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 2.23e-06 | 6 | 169 | 3 | 10588881 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | IPO5 MTG1 COPA UGGT1 RAB1C RPL14 ZDHHC17 IQGAP1 TFRC EHD2 S100A6 RBM25 ERLIN2 AKAP9 MRPL14 SND1 MTIF2 ASXL3 PRKCSH SLC39A14 PRAF2 SAP130 | 2.37e-06 | 1451 | 169 | 22 | 30550785 |
| Pubmed | 2.45e-06 | 20 | 169 | 4 | 21689717 | ||
| Pubmed | IPO5 MYH10 GBF1 ANK3 MYO5A UGGT1 RPL14 ERLIN1 SND1 MICAL2 PDCD11 MACF1 TOP2A TOP2B | 2.98e-06 | 634 | 169 | 14 | 34591612 | |
| Pubmed | IPO5 MYH10 GBF1 COPA GEMIN5 RPL14 IQGAP1 TFRC NCAPG WDHD1 SND1 PDCD11 EIF3B TOP2B | 3.20e-06 | 638 | 169 | 14 | 33239621 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 3.42e-06 | 313 | 169 | 10 | 38270169 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MYH10 COPA UACA MYO5A CENPF UGGT1 RPL14 ITIH2 ERLIN1 TASOR2 IQGAP1 RBM25 SND1 WDR11 CEBPZ PDCD11 GAN EIF3B TOP2A RSBN1L | 3.47e-06 | 1257 | 169 | 20 | 36526897 |
| Pubmed | MYH10 GBF1 MYH13 COPA UACA TAF1C UGGT1 RPL14 FMNL2 CLIP1 ITIH2 ERLIN1 IQGAP1 RBM25 AKAP9 CEBPZ PDCD5 PDCD11 EEA1 SERPINA5 RSBN1L | 3.50e-06 | 1371 | 169 | 21 | 36244648 | |
| Pubmed | 3.68e-06 | 22 | 169 | 4 | 24301466 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYH1 MYH4 MYH8 MYH10 MYH13 COPA MYH7B UGGT1 RPL14 ITIH2 ERLIN1 NCAPG PRKCSH TOP2A | 3.76e-06 | 647 | 169 | 14 | 26618866 |
| Pubmed | 3.89e-06 | 7 | 169 | 3 | 12176734 | ||
| Pubmed | 3.89e-06 | 7 | 169 | 3 | 16819597 | ||
| Pubmed | MYH10 COPA UACA MYO5A UGGT1 FMNL2 IQGAP1 TFRC RBM25 ERLIN2 SND1 MACF1 TOP2A TOP2B | 4.72e-06 | 660 | 169 | 14 | 32780723 | |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 5.89e-06 | 197 | 169 | 8 | 20811636 | |
| Pubmed | 6.20e-06 | 8 | 169 | 3 | 3864153 | ||
| Pubmed | 6.20e-06 | 8 | 169 | 3 | 36200826 | ||
| Pubmed | 7.07e-06 | 340 | 169 | 10 | 24332808 | ||
| Pubmed | 7.07e-06 | 202 | 169 | 8 | 24639526 | ||
| Pubmed | 7.77e-06 | 146 | 169 | 7 | 21399614 | ||
| Pubmed | UGGT1 CHEK1 ZDHHC17 RAB11FIP1 ERLIN1 TFRC ERLIN2 DPH5 WDHD1 WDR11 PDCD5 SYNE2 PRKCSH EIF3B SETD3 RAB13 RSBN1L | 9.19e-06 | 1007 | 169 | 17 | 34597346 | |
| Pubmed | A PAK5-DNPEP-USP4 axis dictates breast cancer growth and metastasis. | 9.27e-06 | 9 | 169 | 3 | 31219614 | |
| Pubmed | 9.39e-06 | 210 | 169 | 8 | 16565220 | ||
| Pubmed | 1.10e-05 | 102 | 169 | 6 | 26584622 | ||
| Pubmed | IPO5 MYH10 COPA UACA CHD9 RPL14 ERLIN1 IQGAP1 DNAH1 RBM25 ERLIN2 AKAP9 CEBPZ MICAL2 WDR87 EIF3B DOT1L RAB13 TOP2A | 1.14e-05 | 1247 | 169 | 19 | 27684187 | |
| Pubmed | 1.16e-05 | 360 | 169 | 10 | 33111431 | ||
| Pubmed | 1.32e-05 | 10 | 169 | 3 | 19506036 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | GBF1 COPA UACA MYO5A TAF1C TAF1A GEMIN5 ERLIN2 SND1 CEBPZ PDCD5 MACF1 DIAPH3 TOP2B | 1.33e-05 | 724 | 169 | 14 | 36232890 |
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | 1.36e-05 | 221 | 169 | 8 | 29991511 | |
| Pubmed | 1.81e-05 | 11 | 169 | 3 | 8136524 | ||
| Pubmed | CASP8AP2 DDX49 ANK3 IFT81 UGGT1 CHEK1 REV3L ERLIN1 BMX ERLIN2 COL21A1 MTIF2 CD36 PRKCSH TNFAIP8 EEA1 SAP130 SH3BP5 PCNT | 1.88e-05 | 1293 | 169 | 19 | 15342556 | |
| Pubmed | 2.00e-05 | 305 | 169 | 9 | 33194618 | ||
| Pubmed | 2.05e-05 | 234 | 169 | 8 | 36243803 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | UACA MYO5A CENPF UGGT1 ZNF318 TFRC AKAP9 SND1 WDR11 CEBPZ MTIF2 EIF3B SLC39A14 PCNT | 2.09e-05 | 754 | 169 | 14 | 33060197 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | GBF1 IQSEC2 CHEK1 DZIP1 RAB11FIP1 TMCC3 ARFGEF3 BMX AKAP9 CEP89 SYNE2 CCSER2 GAN MACF1 CFAP97 | 2.20e-05 | 861 | 169 | 15 | 36931259 |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 24048577 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 23284848 | ||
| Pubmed | Use of divalent metal ions in the dna cleavage reaction of human type II topoisomerases. | 2.35e-05 | 2 | 169 | 2 | 19222228 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 2555055 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 1331984 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 31106979 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 16091284 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 11792814 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 26745340 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 32432789 | ||
| Pubmed | Nesprin-1 and nesprin-2 regulate endothelial cell shape and migration. | 2.35e-05 | 2 | 169 | 2 | 24931616 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 24196961 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 9425062 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 32535049 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 1380833 | ||
| Pubmed | Growth and muscle defects in mice lacking adult myosin heavy chain genes. | 2.35e-05 | 2 | 169 | 2 | 9382868 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 11150240 | ||
| Pubmed | Involvement of human topoisomerase II isoforms in HIV-1 reverse transcription. | 2.35e-05 | 2 | 169 | 2 | 23399433 | |
| Pubmed | The protein tyrosine kinase ZAP-70 can associate with the SH2 domain of proto-Vav. | 2.35e-05 | 2 | 169 | 2 | 7798261 | |
| Pubmed | Enhanced processing of UVA-irradiated DNA by human topoisomerase II in living cells. | 2.35e-05 | 2 | 169 | 2 | 15044480 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 17526531 | ||
| Pubmed | Functional analyses of Pericentrin and Syne-2 interaction in ciliogenesis. | 2.35e-05 | 2 | 169 | 2 | 30054381 | |
| Pubmed | Src-Dependent DBL Family Members Drive Resistance to Vemurafenib in Human Melanoma. | 2.35e-05 | 2 | 169 | 2 | 31416844 | |
| Pubmed | DNA topoisomerase II distribution in mouse preimplantation embryos. | 2.35e-05 | 2 | 169 | 2 | 11835579 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 37913973 | ||
| Pubmed | Role of ERLINs in the Control of Cell Fate through Lipid Rafts. | 2.35e-05 | 2 | 169 | 2 | 34572057 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 2556712 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 10473615 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 9224616 | ||
| Pubmed | DNA damage response during chromatin remodeling in elongating spermatids of mice. | 2.35e-05 | 2 | 169 | 2 | 18032420 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 22111588 | ||
| Pubmed | Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies. | 2.35e-05 | 2 | 169 | 2 | 17578914 | |
| Interaction | LRRC31 interactions | IPO5 MYH4 MYH10 GBF1 COPA UACA MYO5A UGGT1 GEMIN5 IQGAP1 TOP2B | 1.04e-06 | 205 | 165 | 11 | int:LRRC31 |
| Interaction | HDAC1 interactions | IPO5 CASP8AP2 MYH1 MYH4 PADI4 MYH8 MYH10 ARID4A CENPF GEMIN5 ZNF318 ZHX2 POLR3A IQGAP1 TBC1D32 RBM25 NCAPG AKAP9 PDCD5 SYNE2 DIAPH3 DOT1L SAP130 TOP2A TOP2B PCNT | 1.18e-06 | 1108 | 165 | 26 | int:HDAC1 |
| Interaction | BCAP31 interactions | MYH1 MYH4 MYH8 MYH10 MYH13 COPA CENPF MYH7B SND1 MICAL2 SYNE2 PRKCSH SLC39A14 PRAF2 ATP2B2 SERPINA5 CFAP97 | 3.18e-06 | 554 | 165 | 17 | int:BCAP31 |
| Interaction | BRK1 interactions | 8.38e-06 | 124 | 165 | 8 | int:BRK1 | |
| Interaction | SIRT7 interactions | IPO5 MYH10 COPA MYO5A CENPF UGGT1 GEMIN5 ZNF318 RPL14 TASOR2 IQGAP1 RBM25 SND1 CEBPZ SYNE2 PDCD11 MACF1 TOP2A PCNT | 1.15e-05 | 744 | 165 | 19 | int:SIRT7 |
| Interaction | POLR1G interactions | IPO5 DDX49 TAF1C TAF1A CHD9 POLR3A WDHD1 CEBPZ MTIF2 PDCD11 DOT1L PRAF2 TOP2A RSBN1L TOP2B | 1.25e-05 | 489 | 165 | 15 | int:POLR1G |
| Interaction | NPM1 interactions | IPO5 PADI4 MYH10 STAB2 ANK3 MYO5A CENPF TAF1C TAF1A GEMIN5 RPL14 CHEK1 DZIP1 NCAPG SND1 CEBPZ WDR87 SYNE2 CAPRIN2 PDCD11 GAN DOT1L TOP2A RSBN1L TOP2B | 1.56e-05 | 1201 | 165 | 25 | int:NPM1 |
| Interaction | RAB35 interactions | NPHP1 ANK3 UACA MYO5A DZIP1 RAB11FIP1 FMNL2 IQGAP1 TFRC ARFGEF3 CEP89 SYNE2 MACF1 DIAPH3 SLC39A14 RAB13 | 2.02e-05 | 573 | 165 | 16 | int:RAB35 |
| Interaction | GOLGA1 interactions | 2.05e-05 | 183 | 165 | 9 | int:GOLGA1 | |
| Interaction | S100A4 interactions | 2.50e-05 | 144 | 165 | 8 | int:S100A4 | |
| Interaction | DCTN2 interactions | MYH10 GBF1 CLIP1 RBM25 NCAPG TXLNB AKAP9 WDHD1 PRKCSH DIAPH3 SCLT1 PCNT | 3.85e-05 | 356 | 165 | 12 | int:DCTN2 |
| Interaction | PIBF1 interactions | 4.12e-05 | 200 | 165 | 9 | int:PIBF1 | |
| Interaction | NDC80 interactions | UACA IFT81 TOM1L1 SPC25 AKAP9 CEP89 SYNE2 PDCD11 DIAPH3 SCLT1 PCNT | 5.46e-05 | 312 | 165 | 11 | int:NDC80 |
| Interaction | WHAMMP3 interactions | 5.64e-05 | 119 | 165 | 7 | int:WHAMMP3 | |
| Interaction | RHOB interactions | ANK3 UACA RAB8B IQSEC2 CHEK1 RAB11FIP1 FMNL2 ERLIN1 IQGAP1 TFRC EHD2 CEP89 MACF1 DIAPH3 SLC39A14 ARHGAP18 PRAF2 RAB13 TOP2B | 6.05e-05 | 840 | 165 | 19 | int:RHOB |
| Interaction | ATG16L1 interactions | IPO5 ANK3 COPA MYO5A SPC25 GEMIN5 TEC RAB11FIP1 TFRC ARFGEF3 TXLNB MRPL14 SND1 CEP89 CCSER2 SASS6 GAN EIF3B TNFAIP8 DIAPH3 VAV1 TOP2A TOP2B | 7.54e-05 | 1161 | 165 | 23 | int:ATG16L1 |
| Interaction | AGR2 interactions | IPO5 MYH10 ANK3 COPA SYNE1 UGGT1 RPL14 ZAP70 IQGAP1 DNAH1 TFRC S100A6 ERLIN2 AKAP9 SND1 MACF1 PRKCSH EIF3B EEA1 ARHGAP18 | 8.14e-05 | 934 | 165 | 20 | int:AGR2 |
| Interaction | LYN interactions | IPO5 DDX49 ANK3 UACA TOM1L1 DZIP1 TEC RAB11FIP1 FMNL2 IQGAP1 TFRC CEP89 CD36 MACF1 DMD SLC39A14 TOP2B | 9.01e-05 | 720 | 165 | 17 | int:LYN |
| Interaction | TRIM52 interactions | 1.14e-04 | 133 | 165 | 7 | int:TRIM52 | |
| Interaction | KALRN interactions | 1.39e-04 | 96 | 165 | 6 | int:KALRN | |
| Interaction | OFD1 interactions | IPO5 COPA IFT81 SPC25 IQGAP1 S100A6 CEP89 CCSER2 SASS6 DIAPH3 PCNT | 1.40e-04 | 347 | 165 | 11 | int:OFD1 |
| Interaction | LOXL2 interactions | MYH10 COPA MYO5A UGGT1 ERLIN1 TFRC ERLIN2 SND1 MACF1 EEA1 TOP2A TOP2B | 1.47e-04 | 410 | 165 | 12 | int:LOXL2 |
| Interaction | OBSL1 interactions | COPA CENPF SYNE1 RPL14 TASOR2 IQGAP1 DNAH1 BMX RBM25 SND1 CEBPZ TTC29 SYNE2 PDCD11 MACF1 TOP2A RSBN1L TOP2B PCNT | 1.53e-04 | 902 | 165 | 19 | int:OBSL1 |
| Interaction | RAC1 interactions | GBF1 ANK3 RASGRF1 KALRN IQSEC2 MCF2 TEC RAB11FIP1 FMNL2 CLIP1 ERLIN1 IQGAP1 TFRC EHD2 WDR11 CEP89 MACF1 DIAPH3 SLC39A14 VAV1 TOP2A | 1.65e-04 | 1063 | 165 | 21 | int:RAC1 |
| Interaction | RSPH6A interactions | 1.66e-04 | 34 | 165 | 4 | int:RSPH6A | |
| Interaction | CHMP4C interactions | MYH10 COPA LCA5L RPL14 IQGAP1 TFRC S100A6 RBM25 CHMP4A WDR87 PDCD11 MACF1 PRKCSH EIF3B TOP2A TOP2B | 1.71e-04 | 687 | 165 | 16 | int:CHMP4C |
| Interaction | CEP43 interactions | 1.75e-04 | 190 | 165 | 8 | int:CEP43 | |
| Interaction | ABTB2 interactions | 1.83e-04 | 101 | 165 | 6 | int:ABTB2 | |
| Interaction | NIN interactions | MYH13 IFT81 CLIP1 ERLIN1 IQGAP1 ARFGEF3 SASS6 DIAPH3 DOT1L SCLT1 PCNT | 1.88e-04 | 359 | 165 | 11 | int:NIN |
| Interaction | CDC42 interactions | IPO5 MTG1 MYH10 ANK3 COPA SYNE1 MCF2 RAB11FIP1 FMNL2 CLIP1 ERLIN1 IQGAP1 TFRC EHD2 ARFGEF3 WDR11 CEBPZ PDCD5 SYNE2 DIAPH3 SLC39A14 VAV1 TOP2B TRIM60 | 2.00e-04 | 1323 | 165 | 24 | int:CDC42 |
| Interaction | EIF6 interactions | ENOX1 MYO5A RPL14 CHMP4A CEBPZ PDCD11 EIF3B TNFAIP8 DOT1L TOP2A TOP2B | 2.17e-04 | 365 | 165 | 11 | int:EIF6 |
| Interaction | ISG15 interactions | MYH10 COPA UACA MYO5A MYH7B ZNF318 ERLIN1 IQGAP1 TFRC RBM25 SND1 TOP2A TOP2B | 2.22e-04 | 494 | 165 | 13 | int:ISG15 |
| GeneFamily | Myosin heavy chains | 1.79e-10 | 15 | 107 | 6 | 1098 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 2.07e-04 | 4 | 107 | 2 | 1252 | |
| GeneFamily | SH2 domain containing | 3.34e-04 | 101 | 107 | 5 | 741 | |
| GeneFamily | Topoisomerases | 5.12e-04 | 6 | 107 | 2 | 1050 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 6.30e-04 | 66 | 107 | 4 | 722 | |
| GeneFamily | WD repeat domain containing | 9.43e-04 | 262 | 107 | 7 | 362 | |
| GeneFamily | X-linked mental retardation|Angiotensin receptors | 3.81e-03 | 53 | 107 | 3 | 103 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | GBF1 ARID4A CENPF SPC25 CHD9 ATP8B1 REV3L ZDHHC17 ZHX2 CLIP1 AKAP9 WDHD1 ST3GAL5 MICAL2 MTIF2 SYNE2 CCSER2 MACF1 TNFAIP8 DMD SETD3 TOP2A CAP2 PCNT | 9.29e-10 | 856 | 165 | 24 | M4500 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | IPO5 CASP8AP2 MYH10 MYO5A DZIP1 REV3L CLIP1 THAP1 TASOR2 WDHD1 WDR11 CEBPZ SYNE2 CAPRIN2 CEP70 DIAPH3 EEA1 TOP2B | 1.89e-07 | 656 | 165 | 18 | M18979 |
| Coexpression | GSE4590_PRE_BCELL_VS_LARGE_PRE_BCELL_UP | 8.34e-07 | 160 | 165 | 9 | M6863 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP | 2.54e-06 | 183 | 165 | 9 | M2993 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | CENPF CHD9 ZNF318 REV3L ZHX2 AKAP9 WDHD1 MICAL2 MTIF2 TNFAIP8 TOP2A | 3.40e-06 | 300 | 165 | 11 | M8702 |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP | IPO5 CENPF CHEK1 FMNL2 STAR TFRC NCAPG WDHD1 DIAPH3 SLC39A14 TOP2A | 3.98e-06 | 305 | 165 | 11 | M19875 |
| Coexpression | TRAVAGLINI_LUNG_CILIATED_CELL | NPHP1 ABCA13 SYNE1 TTC39C IFT81 LCA5L ODAD4 DZIP1 BBS9 DNAH1 ZBBX EFHC2 AKAP9 CEP89 COL21A1 TTC29 SYNE2 CFAP57 DMD ARHGAP18 IQCG | 5.54e-06 | 1093 | 165 | 21 | M41649 |
| Coexpression | WINNEPENNINCKX_MELANOMA_METASTASIS_UP | 9.03e-06 | 162 | 165 | 8 | M6387 | |
| Coexpression | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2 | NPHP1 MYH10 IFT81 LCA5L ODAD4 DZIP1 REV3L ZBBX EFHC2 TTC29 CEP70 CFAP57 IQCG | 9.65e-06 | 471 | 165 | 13 | M3062 |
| Coexpression | WANG_LMO4_TARGETS_DN | MACC1 KALRN LCA5L RAB11FIP1 IQGAP1 CCDC83 RBM25 CHMP4A AKAP9 MTIF2 DMD | 1.93e-05 | 361 | 165 | 11 | M12674 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | ENOX1 ANK3 MYO5A ARID4A CCDC186 MCF2 ZNF318 REV3L FMNL2 CLIP1 EFHC2 ARFGEF3 TBC1D32 AKAP9 ST3GAL5 ASXL3 CAPRIN2 EEA1 ATP2B2 SH3BP5 | 2.25e-05 | 1106 | 165 | 20 | M39071 |
| Coexpression | GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP | 2.93e-05 | 94 | 165 | 6 | M18983 | |
| Coexpression | CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP | 3.84e-05 | 145 | 165 | 7 | M3045 | |
| Coexpression | GSE24726_WT_VS_E2_2_KO_PDC_UP | 4.12e-05 | 200 | 165 | 8 | M8060 | |
| Coexpression | GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_TREATED_UP | 4.12e-05 | 200 | 165 | 8 | M7442 | |
| Coexpression | ZHENG_CORD_BLOOD_C3_MEGAKARYOCYTE_ERYTHROID_PROGENITOR | 4.15e-05 | 100 | 165 | 6 | M39212 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_DN | 4.89e-05 | 265 | 165 | 9 | M1684 | |
| Coexpression | GSE10147_IL3_AND_HIVP17_VS_IL3_AND_CPG_STIM_PDC_DN | 5.41e-05 | 153 | 165 | 7 | M350 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_DN | 5.98e-05 | 272 | 165 | 9 | MM1027 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | IPO5 CASP8AP2 AEN CENPF TAF1A CHEK1 THUMPD2 FMNL2 STAR TFRC NCAPG DPH5 WDHD1 SND1 MICAL2 PDCD5 SASS6 EIF3B DIAPH3 DMD SLC39A14 TOP2A | 7.63e-05 | 1407 | 165 | 22 | M14427 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | AEN CENPF SPC25 GEMIN5 CHEK1 ODC1 NCAPG WDHD1 CEP89 CEP70 SASS6 ARHGAP18 TOP2A | 7.99e-05 | 578 | 165 | 13 | M2368 |
| Coexpression | BIDUS_METASTASIS_UP | 8.31e-05 | 221 | 165 | 8 | M15866 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_CD5_POS_CCL22_POS_MATURE_B_CELL | AEN GBF1 MYO5A RAB8B RAB11FIP1 TFRC S100A6 CHMP4A DPH5 SYNE2 PDCD11 ARHGAP18 HEATR5B CFAP97 | 8.68e-05 | 666 | 165 | 14 | M45778 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | NPHP1 IPO5 CENPF SPC25 CHEK1 REV3L ARFGEF3 NCAPG WDHD1 SASS6 DOT1L SCLT1 DCBLD2 TOP2A | 1.08e-04 | 680 | 165 | 14 | MM456 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | AEN CENPF SPC25 GEMIN5 CHEK1 ODC1 NCAPG WDHD1 CEP89 CEP70 SASS6 ARHGAP18 TOP2A | 1.10e-04 | 597 | 165 | 13 | MM1309 |
| Coexpression | GSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN | 1.21e-04 | 174 | 165 | 7 | M6881 | |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP | 1.30e-04 | 176 | 165 | 7 | M2981 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL | IPO5 CASP8AP2 DDX49 CENPF TTC39C SPC25 CHEK1 ZAP70 ERLIN1 NCAPG WDHD1 MTIF2 PDCD5 SYNE2 CEP70 SASS6 EIF3B DIAPH3 SCLT1 TOP2A PCNT | 1.38e-04 | 1363 | 165 | 21 | M45782 |
| Coexpression | GSE2935_UV_INACTIVATED_VS_LIVE_SENDAI_VIRUS_INF_MACROPHAGE_DN | 1.50e-04 | 180 | 165 | 7 | M6317 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGM | 1.50e-04 | 307 | 165 | 9 | M39058 | |
| Coexpression | WEI_MYCN_TARGETS_WITH_E_BOX | MYO5A TAF1A GEMIN5 CHEK1 ODC1 ZHX2 THUMPD2 TFRC BMX MRPL14 EIF3B SLC39A14 DOT1L DCBLD2 AKAP7 | 1.53e-04 | 792 | 165 | 15 | M12113 |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 1.62e-04 | 81 | 165 | 5 | M39253 | |
| Coexpression | GAO_ESOPHAGUS_25W_C1_CILIATED_EPITHELIAL_CELLS | NPHP1 ABCA13 SYNE1 IFT81 ODAD4 DNAH1 ZBBX EFHC2 MACF1 CFAP57 ARHGAP18 | 1.66e-04 | 459 | 165 | 11 | M39136 |
| Coexpression | GSE22611_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_2H_DN | 1.66e-04 | 183 | 165 | 7 | M8178 | |
| Coexpression | GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP | 1.77e-04 | 185 | 165 | 7 | M3155 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP | 1.89e-04 | 187 | 165 | 7 | M2984 | |
| Coexpression | ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN | 2.01e-04 | 46 | 165 | 4 | M6792 | |
| Coexpression | GSE1112_HY_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_DN | 2.30e-04 | 193 | 165 | 7 | M6138 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | CENPF CHEK1 ERLIN1 TFRC NCAPG WDHD1 CEBPZ MICAL2 MTIF2 PDCD5 SASS6 DIAPH3 SLC39A14 | 2.31e-04 | 644 | 165 | 13 | M10501 |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_UP | 2.37e-04 | 194 | 165 | 7 | M4187 | |
| Coexpression | GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_UP | 2.52e-04 | 196 | 165 | 7 | M3239 | |
| Coexpression | GSE29618_BCELL_VS_MONOCYTE_DAY7_FLU_VACCINE_UP | 2.52e-04 | 196 | 165 | 7 | M4954 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 2.58e-04 | 20 | 165 | 3 | M1123 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_EARLY_STALK_CELL | AEN UACA CENPF SPC25 CHEK1 BFSP1 TFRC NCAPG WDHD1 DIAPH3 SLC39A14 TOP2A | 2.64e-04 | 567 | 165 | 12 | M45692 |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 2.66e-04 | 90 | 165 | 5 | M39250 | |
| Coexpression | GSE12366_GC_VS_MEMORY_BCELL_UP | 2.68e-04 | 198 | 165 | 7 | M3171 | |
| Coexpression | MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP | 2.75e-04 | 408 | 165 | 10 | M11891 | |
| Coexpression | GSE3982_DC_VS_TH2_DN | 2.77e-04 | 199 | 165 | 7 | M5486 | |
| Coexpression | GSE7852_TREG_VS_TCONV_LN_DN | 2.77e-04 | 199 | 165 | 7 | M5729 | |
| Coexpression | GSE43955_10H_VS_60H_ACT_CD4_TCELL_DN | 2.85e-04 | 200 | 165 | 7 | M9692 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_UP | 2.85e-04 | 200 | 165 | 7 | M9922 | |
| Coexpression | GSE32986_UNSTIM_VS_CURDLAN_LOWDOSE_STIM_DC_UP | 2.85e-04 | 200 | 165 | 7 | M8638 | |
| Coexpression | GSE32164_RESTING_DIFFERENTIATED_VS_CMYC_INHIBITED_MACROPHAGE_UP | 2.85e-04 | 200 | 165 | 7 | M8532 | |
| Coexpression | GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_DN | 2.85e-04 | 200 | 165 | 7 | M7418 | |
| Coexpression | GSE1925_CTRL_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN | 2.85e-04 | 200 | 165 | 7 | M6299 | |
| Coexpression | HALLMARK_G2M_CHECKPOINT | 2.85e-04 | 200 | 165 | 7 | M5901 | |
| Coexpression | GSE23505_IL6_IL1_VS_IL6_IL1_IL23_TREATED_CD4_TCELL_DN | 2.85e-04 | 200 | 165 | 7 | M7859 | |
| Coexpression | GSE38304_MYC_NEG_VS_POS_GC_BCELL_UP | 2.85e-04 | 200 | 165 | 7 | M9273 | |
| Coexpression | GOLDRATH_EFF_VS_MEMORY_CD8_TCELL_DN | 2.85e-04 | 200 | 165 | 7 | M3044 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 3.00e-04 | 21 | 165 | 3 | MM1102 | |
| Coexpression | MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP | 3.15e-04 | 415 | 165 | 10 | MM1028 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | UACA ARID4A MCF2 ATP8B1 FMNL2 CLIP1 TMCC3 ARFGEF3 SNCAIP CD36 MACF1 SHE TNFAIP8 HEATR5B SH3BP5 | 3.42e-04 | 854 | 165 | 15 | M1533 |
| Coexpression | FOURNIER_ACINAR_DEVELOPMENT_LATE_DN | 3.45e-04 | 22 | 165 | 3 | M13202 | |
| Coexpression | BENPORATH_PROLIFERATION | 3.46e-04 | 147 | 165 | 6 | M2114 | |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | 3.86e-04 | 426 | 165 | 10 | M9516 | |
| Coexpression | GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP | 4.13e-04 | 152 | 165 | 6 | M2938 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGFPM | 4.27e-04 | 354 | 165 | 9 | M39061 | |
| Coexpression | GSE11818_WT_VS_DICER_KO_TREG_DN | 4.43e-04 | 154 | 165 | 6 | M411 | |
| Coexpression | MURARO_PANCREAS_DUCTAL_CELL | MACC1 ANK3 ATP8B1 ODC1 ACSS2 RAB11FIP1 FMNL2 IQGAP1 TFRC S100A6 ERLIN2 SYNE2 MACF1 TNFAIP8 ARHGAP18 DCBLD2 SERPINA5 TOP2B AKAP7 | 4.46e-04 | 1276 | 165 | 19 | M39173 |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | CASP8AP2 CENPF IFT81 CHEK1 TFRC NCAPG AKAP9 WDR11 TOP2A CFAP97 | 4.47e-04 | 434 | 165 | 10 | M15150 |
| Coexpression | COLLER_MYC_TARGETS_UP | 4.50e-04 | 24 | 165 | 3 | M5955 | |
| Coexpression | VERHAAK_GLIOBLASTOMA_MESENCHYMAL | 4.53e-04 | 216 | 165 | 7 | M2122 | |
| Coexpression | NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON | 4.61e-04 | 57 | 165 | 4 | M8293 | |
| Coexpression | GRYDER_PAX3FOXO1_TOP_ENHANCERS | 5.06e-04 | 441 | 165 | 10 | M172 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | UACA ARID4A MCF2 ATP8B1 FMNL2 CLIP1 TMCC3 ARFGEF3 SNCAIP CD36 MACF1 SHE TNFAIP8 HEATR5B SH3BP5 | 5.13e-04 | 888 | 165 | 15 | MM1018 |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | IPO5 CENPF RPL14 CHEK1 ODC1 TFRC NCAPG DPH5 PDCD11 EIF3B SAP130 TOP2A | 5.22e-04 | 612 | 165 | 12 | M4772 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL1 | 5.22e-04 | 364 | 165 | 9 | M39057 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_PROMONOCYTE_LIKE_CELL | 5.23e-04 | 290 | 165 | 8 | M45736 | |
| Coexpression | BROWNE_HCMV_INFECTION_14HR_DN | 5.23e-04 | 290 | 165 | 8 | M13251 | |
| Coexpression | NABA_MATRISOME_HGSOC_OMENTAL_METASTASIS | 5.26e-04 | 59 | 165 | 4 | M47993 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | ANK3 ARID4A MCF2 REV3L STAR ARFGEF3 TBC1D32 AKAP9 ASXL3 EEA1 ATP2B2 AKAP7 SH3BP5 | 5.31e-04 | 703 | 165 | 13 | M39070 |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | CASP8AP2 CENPF IFT81 CHEK1 TFRC NCAPG AKAP9 WDR11 TOP2A CFAP97 | 5.72e-04 | 448 | 165 | 10 | MM1044 |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_GRAN_MONO_PROGENITOR_UP | 5.79e-04 | 162 | 165 | 6 | M8883 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_CYCLING_DEFINITIVE_ERYTHROBLAST | 5.91e-04 | 450 | 165 | 10 | M45747 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | CASP8AP2 MYO5A ARID4A CENPF REV3L CLIP1 AKAP9 CEBPZ HECTD2 MTIF2 SYNE2 CEP70 TOP2B | 7.63e-07 | 311 | 161 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | CASP8AP2 MYH10 MYO5A ARID4A CENPF IFT81 SPC25 CHD9 REV3L FMNL2 CLIP1 RBM25 NCAPG AKAP9 HECTD2 MTIF2 PDCD5 SYNE2 CEP70 SASS6 MACF1 DMD SCLT1 TOP2A CFAP97 AKAP7 | 2.88e-06 | 1257 | 161 | 26 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | Fetal Liver, SC.STSL.FL, IgM- CD24- CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Fetal Liver, avg-2 | MYH10 STAB2 CENPF TOM1L1 SPC25 CHEK1 FMNL2 NCAPG WDHD1 CD36 SYNE2 DIAPH3 TOP2A | 1.55e-05 | 410 | 161 | 13 | GSM791122_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_1000 | NPHP1 ENOX1 ANK3 KALRN NTF3 TOM1L1 RPL14 CHEK1 DZIP1 REV3L JMY ITIH2 TFRC NCAPG SNCAIP SASS6 TOP2B CAP2 | 2.69e-05 | 779 | 161 | 18 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | CASP8AP2 MYH10 MYO5A ARID4A CENPF IFT81 SPC25 CHD9 REV3L FMNL2 CLIP1 RBM25 NCAPG AKAP9 HECTD2 MTIF2 PDCD5 SYNE2 CEP70 SASS6 MACF1 DMD SCLT1 TOP2A CFAP97 AKAP7 | 3.92e-05 | 1459 | 161 | 26 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | alpha beta T cells, NKT.44+NK1.1-.Th, aGC CD1d tet CD3 CD44, Thymus, avg-3 | STAB2 TTC39C SPC25 CHEK1 DZIP1 ZAP70 S100A6 NCAPG WDHD1 DIAPH3 TOP2A CAP2 | 4.66e-05 | 392 | 161 | 12 | GSM538335_500 |
| CoexpressionAtlas | B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R+ CD117+ IL7R+, Bone marrow, avg-1 | PADI4 CENPF ABCA13 SYNE1 SPC25 CHEK1 FMNL2 TFRC BMX NCAPG ST3GAL5 TOP2A | 5.02e-05 | 395 | 161 | 12 | GSM538351_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | NPHP1 MYH10 CCDC186 SYNE1 TTC39C DZIP1 REV3L ZDHHC17 EHD2 RBM25 SNCAIP HECTD2 ASXL3 CEP70 MACF1 TNFAIP8 SCLT1 | 5.24e-05 | 744 | 161 | 17 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_500 | ENOX1 ANK3 NTF3 TOM1L1 RPL14 REV3L JMY ITIH2 TFRC SNCAIP TOP2B CAP2 | 5.80e-05 | 401 | 161 | 12 | gudmap_developingKidney_e15.5_Cap mesenchyme_500 |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R+ CD, Fetal Liver, avg-2 | 5.98e-05 | 89 | 161 | 6 | GSM538355_100 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.Th, TCRd+ CD3e+, Thymus, avg-3 | CENPF SPC25 CHEK1 DZIP1 ZAP70 TFRC NCAPG HECTD2 DIAPH3 TOP2A CAP2 | 7.50e-05 | 349 | 161 | 11 | GSM476675_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | MYH8 COPA MYO5A GEMIN5 CHD9 ZNF318 CHEK1 ACSS2 TASOR2 SYCP2 RBM25 NCAPG HECTD2 SYNE2 GAN CFAP97 SMC1B | 8.77e-05 | 776 | 161 | 17 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | Fetal Liver, SC.LTSL.FL, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Fetal Liver, avg-3 | MYH10 CENPF TOM1L1 SPC25 CHEK1 FMNL2 TFRC NCAPG WDHD1 ST3GAL5 DIAPH3 TOP2A | 9.63e-05 | 423 | 161 | 12 | GSM791126_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | MYH10 ARID4A CCDC186 SYNE1 REV3L CLIP1 SNCAIP CEP70 MACF1 TNFAIP8 HEATR5B SCLT1 | 1.17e-04 | 432 | 161 | 12 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6+.Th, TCRd+ Vd6.3+ Vg1.1+, Thymus, avg-1 | 1.26e-04 | 308 | 161 | 10 | GSM605775_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6-.Th, TCRd+ Vg1.1+, Thymus, avg-3 | CENPF SPC25 CHEK1 DZIP1 ZAP70 TFRC NCAPG HECTD2 DIAPH3 TOP2A CAP2 | 1.35e-04 | 373 | 161 | 11 | GSM605781_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_500 | MYH8 COPA MYO5A ZNF318 CHEK1 SYCP2 NCAPG SYNE2 GAN CFAP97 SMC1B | 1.66e-04 | 382 | 161 | 11 | gudmap_developingGonad_e14.5_ ovary_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000 | MTG1 ARID4A CENPF REV3L CLIP1 ERLIN1 DPH5 AKAP9 CEP89 C7orf25 ASXL3 PDCD5 SYNE2 CCSER2 CEP70 MACF1 HEATR5B RAB13 CAP2 | 1.76e-04 | 985 | 161 | 19 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | CASP8AP2 MYH10 ANK3 CENPF MYH7B CCDC186 IFT81 SPC25 CHD9 DZIP1 ODC1 RBM25 NCAPG AKAP9 HECTD2 ASXL3 PDCD5 CEP70 MACF1 SCLT1 TOP2A TOP2B | 1.77e-04 | 1241 | 161 | 22 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500 | CASP8AP2 CENPF ZNF318 CHEK1 TASOR2 TFRC SYCP2 NCAPG WDHD1 CAPRIN2 SMC1B | 1.78e-04 | 385 | 161 | 11 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | MYH10 ENOX1 ARID4A CENPF CCDC186 SYNE1 REV3L CLIP1 SNCAIP AKAP9 MTIF2 PDCD5 SYNE2 CEP70 MACF1 TNFAIP8 HEATR5B SCLT1 ATP2B2 | 1.85e-04 | 989 | 161 | 19 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | CASP8AP2 MYO5A ARID4A CENPF FMNL2 CLIP1 DPH5 AKAP9 CEP89 CEBPZ MTIF2 SYNE2 CCSER2 EEA1 DMD TOP2B CAP2 | 1.99e-04 | 831 | 161 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6+.Th, TCRd+ Vg1.1+ Vd6.3+, Thymus, avg-2 | TTC39C SPC25 RPL14 CHEK1 DZIP1 ZAP70 S100A6 NCAPG TOP2A CAP2 | 2.09e-04 | 328 | 161 | 10 | GSM605776_500 |
| CoexpressionAtlas | alpha beta T cells, NKT.44-NK1.1-.Th, aGC CD1d tet CD3e, Thymus, avg-2 | CENPF TTC39C SPC25 CHEK1 DZIP1 ZAP70 TFRC NCAPG DIAPH3 TOP2A CAP2 | 2.36e-04 | 398 | 161 | 11 | GSM538338_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.46e-04 | 115 | 161 | 6 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k2 | |
| CoexpressionAtlas | Stem Cells, SC.CDP.BM, Sca1- Flt3+ MCSFR+ cKitlo, Bone marrow, avg-3 | CENPF SPC25 CHEK1 FMNL2 ERLIN1 TFRC S100A6 NCAPG WDHD1 DIAPH3 TOP2A | 2.52e-04 | 401 | 161 | 11 | GSM791114_500 |
| CoexpressionAtlas | alpha beta T cells, T.8SP24int.Th, 4- 8+ TCRhi 24int, Thymus, avg-3 | SPC25 CHEK1 DZIP1 ZAP70 TFRC NCAPG WDHD1 HECTD2 DIAPH3 TOP2A | 2.72e-04 | 339 | 161 | 10 | GSM399382_500 |
| CoexpressionAtlas | B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R- CD117+ IL7R+, Bone marrow, avg-1 | PADI4 MYO5A ABCA13 SYNE1 CHEK1 FMNL2 TFRC BMX NCAPG ST3GAL5 TOP2A | 2.74e-04 | 405 | 161 | 11 | GSM538343_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | ARID4A CENPF CCDC186 REV3L CLIP1 DPH5 AKAP9 HECTD2 SYNE2 CEP70 MACF1 EEA1 HEATR5B CFAP97 TOP2B CAP2 | 2.99e-04 | 780 | 161 | 16 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6+.Th, TCRd+ Vg1.1+ Vd6.3+, Thymus, avg-2 | 3.18e-04 | 78 | 161 | 5 | GSM605776_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_500 | 3.18e-04 | 78 | 161 | 5 | gudmap_developingKidney_e15.5_Cap mesenchyme_500_k5 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.e17.Th, TCRd+ Vg2+ CD24+, Fetal Thymus, avg-3 | CENPF SPC25 CHEK1 DZIP1 ZAP70 TFRC NCAPG WDHD1 HECTD2 DIAPH3 TOP2A | 3.31e-04 | 414 | 161 | 11 | GSM476660_500 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.54e-04 | 123 | 161 | 6 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | MYH8 COPA MYO5A GEMIN5 CHD9 ZNF318 EFHC2 SYCP2 RBM25 NCAPG ST3GAL5 SYNE2 CAPRIN2 GAN CFAP97 SMC1B | 3.69e-04 | 795 | 161 | 16 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-24ahi.Th, TCRd+ Vg2- CD24+, Thymus, avg-2 | CENPF SPC25 CHEK1 DZIP1 ZAP70 TFRC NCAPG HECTD2 DIAPH3 TOP2A CAP2 | 3.88e-04 | 422 | 161 | 11 | GSM476658_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 3.91e-04 | 291 | 161 | 9 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | ARID4A CENPF GEMIN5 ZNF318 TASOR2 TBC1D32 SYCP2 NCAPG WDHD1 CAPRIN2 CEP70 PDCD11 EIF3B SETD3 SMC1B IQCG | 4.52e-04 | 810 | 161 | 16 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 4.65e-04 | 298 | 161 | 9 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | B cells, proB.FrBC.FL, CD19+ IgM- CD43+ CD24+ AA4.1+ CD45R+, Fetal Liver, avg-3 | 4.74e-04 | 85 | 161 | 5 | GSM538358_100 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | CASP8AP2 MYH10 ARID4A CENPF CCDC186 CHD9 DZIP1 REV3L CLIP1 RBM25 SNCAIP AKAP9 ST3GAL5 HECTD2 SYNE2 CEP70 TNFAIP8 SCLT1 CFAP97 TOP2B AKAP7 | 5.23e-04 | 1252 | 161 | 21 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-24ahi.Th, TCRd+ Vg2- CD24+, Thymus, avg-2 | 5.27e-04 | 87 | 161 | 5 | GSM476658_100 | |
| CoexpressionAtlas | B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3 | 5.56e-04 | 88 | 161 | 5 | GSM399452_100 | |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Fetal Liver, avg-1 | 5.56e-04 | 88 | 161 | 5 | GSM538357_100 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | CASP8AP2 MYH10 KALRN CENPF DZIP1 REV3L FMNL2 NCAPG WDHD1 MICAL2 ASXL3 SYNE2 DIAPH3 DCBLD2 TOP2A CAP2 | 5.66e-04 | 827 | 161 | 16 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | Stem Cells, SC.MEP.BM, Lineage- Kit+ Sca1- CD34- FcgR-/low, Bone marrow, avg-2 | 5.85e-04 | 89 | 161 | 5 | GSM791108_100 | |
| CoexpressionAtlas | alpha beta T cells, NKT.44-NK1.1-.Th, aGC CD1d tet CD3e, Thymus, avg-2 | 6.16e-04 | 90 | 161 | 5 | GSM538338_100 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_500 | 6.51e-04 | 379 | 161 | 10 | gudmap_developingGonad_P2_ovary_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 6.70e-04 | 192 | 161 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 6.70e-04 | 192 | 161 | 7 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | CASP8AP2 MYO5A ARID4A CENPF IFT81 LCA5L CHD9 REV3L FMNL2 CLIP1 TFRC RBM25 DPH5 AKAP9 ST3GAL5 SYNE2 CAPRIN2 SASS6 DMD SCLT1 TOP2A TOP2B | 6.86e-04 | 1370 | 161 | 22 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Bone marrow, avg-2 | 7.79e-04 | 388 | 161 | 10 | GSM538352_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | COPA MYO5A MCF2 GEMIN5 CHEK1 TMCC3 BFSP1 SYCP2 NCAPG ST3GAL5 SYNE2 GAN EEA1 CFAP97 SMC1B | 7.87e-04 | 770 | 161 | 15 | gudmap_developingGonad_P2_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | COPA MYO5A GEMIN5 ZNF318 CHEK1 TMCC3 EFHC2 SYCP2 NCAPG SYNE2 CAPRIN2 GAN EEA1 CFAP97 SMC1B | 8.74e-04 | 778 | 161 | 15 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | B cells, B.Pl.AA4-.BM, CD138+ AA4.1- CD43+, Bone marrow, avg-2 | PADI4 CENPF ABCA13 SYNE1 SPC25 CHEK1 NCAPG ST3GAL5 SYNE2 TOP2A | 8.75e-04 | 394 | 161 | 10 | GSM777030_500 |
| CoexpressionAtlas | B cells, preB.FrD.FL, AA4.1+ IgM- CD19+ CD43- CD24+, Fetal Liver, avg-3 | 8.92e-04 | 395 | 161 | 10 | GSM538340_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4Nve.PP, TCR+ CD4+ CD44low CD62Lhigh, Peyer's Patch, avg-2 | 9.00e-04 | 327 | 161 | 9 | GSM538380_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 9.28e-04 | 203 | 161 | 7 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4 | |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | CENPF SPC25 CHEK1 DZIP1 ZAP70 NCAPG SASS6 DIAPH3 SCLT1 TOP2A | 9.45e-04 | 398 | 161 | 10 | GSM399397_500 |
| CoexpressionAtlas | B cells, proB.FrBC.FL, CD19+ IgM- CD43+ CD24+ AA4.1+ CD45R+, Fetal Liver, avg-3 | 9.81e-04 | 400 | 161 | 10 | GSM538358_500 | |
| CoexpressionAtlas | Stem Cells, SC.MEP.BM, Lineage- Kit+ Sca1- CD34- FcgR-/low, Bone marrow, avg-2 | MYH10 SPC25 CHEK1 ODC1 TFRC NCAPG WDHD1 ST3GAL5 DIAPH3 TOP2A | 1.00e-03 | 401 | 161 | 10 | GSM791108_500 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d6.LisOva, CD8+ CD45.1+, Spleen, avg-3 | CENPF TTC39C SPC25 CHEK1 ACSS2 ZAP70 S100A6 NCAPG DIAPH3 TOP2A | 1.02e-03 | 402 | 161 | 10 | GSM605898_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | MYH10 ENOX1 ARID4A CENPF CHD9 CLIP1 AKAP9 MTIF2 SYNE2 MACF1 DMD HEATR5B SCLT1 | 1.04e-03 | 629 | 161 | 13 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | CENPF SPC25 CHEK1 RAB11FIP1 TFRC SYCP2 NCAPG WDHD1 CEBPZ CAPRIN2 CEP70 PDCD11 EIF3B SMC1B IQCG | 1.09e-03 | 795 | 161 | 15 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.16e-03 | 339 | 161 | 9 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| CoexpressionAtlas | B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3 | 1.16e-03 | 409 | 161 | 10 | GSM399452_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | CASP8AP2 MYO5A CENPF CHD9 ACSS2 CLIP1 RBM25 AKAP9 ST3GAL5 HECTD2 MTIF2 SYNE2 CAPRIN2 CEP70 SASS6 MACF1 DMD SCLT1 | 1.16e-03 | 1060 | 161 | 18 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | CENPF TTC39C SPC25 CHEK1 ZAP70 S100A6 NCAPG WDHD1 DIAPH3 TOP2A | 1.18e-03 | 410 | 161 | 10 | GSM538387_500 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.Th.TCRbko, TCRd+ Vg2+ CD24+, Thymus, avg-3 | CENPF SPC25 CHEK1 DZIP1 ZAP70 TFRC NCAPG HECTD2 DIAPH3 TOP2A | 1.22e-03 | 412 | 161 | 10 | GSM605793_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_500 | 1.23e-03 | 156 | 161 | 6 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_500_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 1.24e-03 | 105 | 161 | 5 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500 | ARID4A CENPF REV3L CLIP1 AKAP9 ASXL3 PDCD5 SYNE2 CEP70 MACF1 HEATR5B | 1.36e-03 | 492 | 161 | 11 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500 |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Fetal Liver, avg-1 | 1.36e-03 | 418 | 161 | 10 | GSM538350_500 | |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Fetal Liver, avg-2 | 1.39e-03 | 419 | 161 | 10 | GSM538348_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg3+24alo.e17.Th, TCRd+ Vg3+ CD24-, Fetal Thymus, avg-3 | CENPF SPC25 CHEK1 ZAP70 TFRC S100A6 NCAPG WDHD1 DIAPH3 TOP2A | 1.39e-03 | 419 | 161 | 10 | GSM476664_500 |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | NPHP1 ABCA13 SYNE1 IFT81 ODAD4 ZBBX COL21A1 TTC29 CFAP57 IQCG | 3.67e-09 | 194 | 168 | 10 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | NPHP1 CENPF LCA5L ZBBX AKAP9 CFAP77 COL21A1 TTC29 CFAP57 IQCG | 4.46e-09 | 198 | 168 | 10 | 1847ce8c344c8a3e50f3cbbf758a38aba69f85b0 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-08 | 184 | 168 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-08 | 184 | 168 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-08 | 184 | 168 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 3.72e-08 | 185 | 168 | 9 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 4.73e-08 | 135 | 168 | 8 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | COVID-19-T_cells|COVID-19 / group, cell type (main and fine annotations) | 4.90e-08 | 191 | 168 | 9 | 7f64add931b64b8d35836fa6bee9ebab593844d3 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.36e-08 | 193 | 168 | 9 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | Influenza_Severe-T/NK_proliferative|World / Disease group and Cell class | 5.85e-08 | 195 | 168 | 9 | 6f079c2d7d08110a5e1822ea861b8037eb3f62c9 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 6.12e-08 | 196 | 168 | 9 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 6.12e-08 | 196 | 168 | 9 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.39e-08 | 197 | 168 | 9 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.39e-08 | 197 | 168 | 9 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.39e-08 | 197 | 168 | 9 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.39e-08 | 197 | 168 | 9 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.39e-08 | 197 | 168 | 9 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | mild-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.39e-08 | 197 | 168 | 9 | bd9d57e0c873f6526dca322f4dad8e6bd692586c | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.67e-08 | 198 | 168 | 9 | 80b105a7c7d00ea3b5e586831fbb755bd84f9d1a | |
| ToppCell | (0)_NK_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.67e-08 | 198 | 168 | 9 | 5ebb4965b723302152b42bfaf48bb77a57dd02c5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.67e-08 | 198 | 168 | 9 | c73e906d2d12d6eba0e606958be16e63a2292cd0 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 6.97e-08 | 199 | 168 | 9 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | COVID-19_Mild-Myeloid_G-immature_Neutrophil|COVID-19_Mild / Disease group, lineage and cell class | 2.47e-07 | 113 | 168 | 7 | fc3417c379f871a4aec3edef953baaa00755c472 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.63e-07 | 114 | 168 | 7 | 613714fd15ad6d553e63d8538ad53bc1ded6bd6c | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.80e-07 | 170 | 168 | 8 | e08a6c5ac34c456da8c7318f104e06fca585be1f | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.06e-07 | 172 | 168 | 8 | 2b6cd84c946b1e800caba452ae70145ea285fec1 | |
| ToppCell | droplet-Spleen-SPLEEN-30m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-07 | 172 | 168 | 8 | 02cc4a9fb7902c572cee37ba828749db4913ee87 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.49e-07 | 175 | 168 | 8 | 284fdc7a9d303636a637041846850d19d114861a | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.81e-07 | 177 | 168 | 8 | 8a74f5e72de605774111057bd87a7e7e4a6385cd | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Activated_DCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 3.81e-07 | 177 | 168 | 8 | 370aee11a6dc2c6f4366a13c3171f37bc5b32d65 | |
| ToppCell | Dividing_Macrophages-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 3.98e-07 | 178 | 168 | 8 | 6557688c6790a5bcc3b9aea5b8789cf9506b3c54 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.15e-07 | 179 | 168 | 8 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.15e-07 | 179 | 168 | 8 | 54191c00b29f53b520cd3243b5791daa4a2c72d7 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.33e-07 | 180 | 168 | 8 | 0c146e80d55d18b6988dd21b1da635801bd3140c | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.33e-07 | 180 | 168 | 8 | 5e1680088065be14447d5d5465f91f7edd071a1e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.33e-07 | 180 | 168 | 8 | e9af22beae2f3c7fe213b4e19df84abfd2453433 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.33e-07 | 180 | 168 | 8 | 11455ba704ac73f69b474845136cfecec6a88349 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.91e-07 | 183 | 168 | 8 | 6c1d7ce60e67bf1df364a4e177c351e7313eb41f | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.92e-07 | 125 | 168 | 7 | d05556ea185c15815a4f8643f1c01185badbeece | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 5.11e-07 | 184 | 168 | 8 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 5.33e-07 | 185 | 168 | 8 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Proliferating_T_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.33e-07 | 185 | 168 | 8 | 0e0f043ad6d2a62cd47ce39911ad81feab4a4d7e | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.33e-07 | 185 | 168 | 8 | 89b85ce8026dc80c1bd9f76dfe16401c173b7946 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.55e-07 | 186 | 168 | 8 | 7cdcf507a9a1349ed2cf62b79116367c3fc732dd | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.55e-07 | 186 | 168 | 8 | ac6e32cf07f0f013101ca7aedae0c562857f182b | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-Cycling_Dendritic|lymph-node_spleen / Manually curated celltypes from each tissue | 6.02e-07 | 188 | 168 | 8 | 723348a1836a074e068320cb736ce6a953e0038f | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 6.26e-07 | 189 | 168 | 8 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | droplet-Spleen-nan-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.52e-07 | 190 | 168 | 8 | a273fc119baebc11020009c923beafeebb6428c9 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-07 | 191 | 168 | 8 | c8b99bd3a30c81ee4deba9cbf0196920ab3ab550 | |
| ToppCell | ASK440-Epithelial-Ciliated|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.34e-07 | 193 | 168 | 8 | a0baa8be6f590b2031fede22be588715ae458e93 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.34e-07 | 193 | 168 | 8 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.34e-07 | 193 | 168 | 8 | bbdfda6665941cfa1965418bb91ef9ff43b1326f | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 7.34e-07 | 193 | 168 | 8 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.34e-07 | 193 | 168 | 8 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.63e-07 | 194 | 168 | 8 | 590a9d4f054e6a3685daf752c9354650fcc7d18a | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.93e-07 | 195 | 168 | 8 | d211a836cf711fdb91b10d512f09d462be937cc5 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.93e-07 | 195 | 168 | 8 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 7.93e-07 | 195 | 168 | 8 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-hematologic-hematopoietic_progenitor-erythroid_progenitor_cell|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.24e-07 | 196 | 168 | 8 | c391d6359634145455c71c7f051bf34ff0eb666d | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.56e-07 | 197 | 168 | 8 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.56e-07 | 197 | 168 | 8 | 6e4a411ef823ce9e16f420e185e21fa19d13af34 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Deuterosomal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.89e-07 | 198 | 168 | 8 | f31790442ef142f1c0c49bf3daf2d0efb193d2c9 | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.89e-07 | 198 | 168 | 8 | e36303628af3139310c1d7a84d2919b7319bbda4 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.89e-07 | 198 | 168 | 8 | 428182c71f009906c581e02257e545ea5fb99650 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.89e-07 | 198 | 168 | 8 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.24e-07 | 199 | 168 | 8 | 305a9ade5bbe8e981e7c641c9a5e0c9f8ef60470 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Proliferating_Epithelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 9.24e-07 | 199 | 168 | 8 | 4fcf5bec207e4384fd73c5e8801a7e414e3ee7b0 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.24e-07 | 199 | 168 | 8 | 101f78fe6dd1bf9e2e4dd5ad8a970312b3540927 | |
| ToppCell | Influenza_Severe-T/NK_proliferative|Influenza_Severe / Disease group and Cell class | 9.24e-07 | 199 | 168 | 8 | 2508c55f9ffe17b694c70f1283f41ad4a8e83c00 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 9.24e-07 | 199 | 168 | 8 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.24e-07 | 199 | 168 | 8 | e0fcec796afe75e42467ca86355b9fc5aa9ae0a1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.24e-07 | 199 | 168 | 8 | fba48342066aab41a8bcb20db40a6df0158e1cbe | |
| ToppCell | Severe_COVID-19-T/NK-proliferating_T/NK|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 9.59e-07 | 200 | 168 | 8 | 52265e761a961f3724b388285e0919bd58847138 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.59e-07 | 200 | 168 | 8 | 3c3ac587ad98e3f6be809eac18c7742a23140de1 | |
| ToppCell | (09)_Interm._secr.>cil.|World / shred by cell type by condition | 9.59e-07 | 200 | 168 | 8 | 3305e14dba12e94da42f0414fdc7a2c8caf0a183 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.59e-07 | 200 | 168 | 8 | f1a49bc818054fb0734d3b84725ee6487b034567 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.59e-07 | 200 | 168 | 8 | dd7ad295ab3ba4c19babffb1625900db414bb5a9 | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-T/NK-T/NK_proliferative|Influenza_Severe / Disease, condition lineage and cell class | 9.59e-07 | 200 | 168 | 8 | e1c266525ce6b42a4451b6a3b0cabf41ff5e2ee7 | |
| ToppCell | (10)_Ciliated|World / shred by cell type by condition | 9.59e-07 | 200 | 168 | 8 | 1b6a8025bd2746b626040058c122b1be3ab2fa61 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.59e-07 | 200 | 168 | 8 | 535f6fba8d03873ba35c9949579161dc41cd7a60 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.59e-07 | 200 | 168 | 8 | 5c84aaedac9f27da0da0493dab7c8f7a4d66888c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.59e-07 | 200 | 168 | 8 | 562309f9ca4a73cea5ed1d85b516891545f3ae5f | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.59e-07 | 200 | 168 | 8 | 60d11275f06490f86f400a2802492f9c1b570400 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Ciliated|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 9.59e-07 | 200 | 168 | 8 | d7ae09189cf0b7e2f7e7fc6b0921975b75aa7d62 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.59e-07 | 200 | 168 | 8 | 0e44a55d65b72eb40543d3bde301f8598ac251c3 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.59e-07 | 200 | 168 | 8 | cf59110547cc66b5f4a2999735336b0309ba9b0d | |
| ToppCell | COVID-19_Mild-Neu_2|World / 5 Neutrophil clusters in COVID-19 patients | 1.06e-06 | 140 | 168 | 7 | b1429028c52f84127b894b93b55961badcd5246f | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-06 | 162 | 168 | 7 | 6972d45f4bd4b6522bf93295f7e9dca7c6cba1f3 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-06 | 164 | 168 | 7 | 2a230ea066decb798a0e6f2b96c7608c8e608031 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-06 | 164 | 168 | 7 | d02d39edd0bfef5a53b814ec6d5f026d41253218 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Dendritic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.56e-06 | 168 | 168 | 7 | 9b8a74abb83c64f0b5829dcb4275f722c82b45dc | |
| ToppCell | PND14-Immune-Immune_Myeloid-Dendritic-cDC1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.56e-06 | 168 | 168 | 7 | 4b152b8d0f4a66faf664dfacb7914b18d60ce64a | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-06 | 168 | 168 | 7 | 35ce3b2b9c9997d4c101da5949c7271d6a6b8f12 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Dendritic-cDC1-cDC1_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.56e-06 | 168 | 168 | 7 | c3169ad8f4130ef18777ed86770bb722ffb5db85 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.70e-06 | 169 | 168 | 7 | a949f547b53126a208819bade74a1ac9b2a36ea7 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.70e-06 | 169 | 168 | 7 | 195d5cd60d646ac6d40a3321b2f739917e7aef14 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.70e-06 | 169 | 168 | 7 | 54b13ab02b4c187f4754045ecfcf409749e7ccc0 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.70e-06 | 169 | 168 | 7 | 563c267edaade0e5df192ad953801ef9768d4270 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.73e-06 | 62 | 168 | 5 | a20620a8869721ea62984c2022ee1b484b455824 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.73e-06 | 62 | 168 | 5 | ee694c06bcd924b4ddf744178ba3a99e04eed51b | |
| Drug | formycin triphosphate | 8.18e-08 | 51 | 165 | 7 | CID000122274 | |
| Drug | B0683 | 1.87e-07 | 117 | 165 | 9 | CID006398969 | |
| Drug | purealin | 2.04e-07 | 58 | 165 | 7 | CID006419303 | |
| Drug | nocodazole | MYH1 MYH4 MYH8 MYH10 GBF1 MYH13 MYO5A MYH7B CHEK1 CLIP1 IQGAP1 TFRC AKAP9 KIF2B EEA1 PCNT | 4.18e-07 | 477 | 165 | 16 | CID000004122 |
| Drug | fast white | 5.59e-07 | 42 | 165 | 6 | CID000024008 | |
| Drug | NSC339663 | MYH1 MYH4 MYH8 MYH10 MYH13 MYO5A MYH7B SYNE1 MCF2 SYNE2 EEA1 | 2.23e-06 | 250 | 165 | 11 | CID000003892 |
| Drug | oxovanadium | 2.71e-06 | 120 | 165 | 8 | CID000024411 | |
| Drug | carvedilol | 2.76e-06 | 161 | 165 | 9 | CID000002585 | |
| Drug | Spermine | 6.39e-06 | 63 | 165 | 6 | ctd:D013096 | |
| Drug | S-(-)-Etomoxir | 8.40e-06 | 100 | 165 | 7 | CID000060765 | |
| Drug | clenbuterol | 9.45e-06 | 142 | 165 | 8 | CID000002783 | |
| Drug | candesartan cilexetil | 1.10e-05 | 145 | 165 | 8 | CID000002540 | |
| Drug | AC1N9ZZC | 1.34e-05 | 149 | 165 | 8 | CID004369374 | |
| Drug | blebbistatin | 2.22e-05 | 116 | 165 | 7 | CID003476986 | |
| Drug | wartmannin | MYH1 MYH4 MYH8 MYH10 MYH13 MYO5A MYH7B NTF3 TOM1L1 CHEK1 TEC ZHX2 TFRC BMX CD36 TNFAIP8 EEA1 VAV1 | 2.56e-05 | 811 | 165 | 18 | CID000005691 |
| Drug | 2bq7 | 3.24e-05 | 123 | 165 | 7 | CID006540267 | |
| Drug | SM-2 | 4.11e-05 | 87 | 165 | 6 | CID000486033 | |
| Drug | imazaquin | 4.32e-05 | 10 | 165 | 3 | CID000054739 | |
| Drug | Dexrazoxane | 5.22e-05 | 2 | 165 | 2 | DB00380 | |
| Drug | AC1NSWD2 | 5.22e-05 | 2 | 165 | 2 | CID005318091 | |
| Drug | F14512 | 5.22e-05 | 2 | 165 | 2 | ctd:C534191 | |
| Drug | Daunorubicin | 5.22e-05 | 2 | 165 | 2 | DB00694 | |
| Drug | thioflavone | 5.22e-05 | 2 | 165 | 2 | CID000069914 | |
| Drug | IQ-3 | 5.91e-05 | 11 | 165 | 3 | CID000028212 | |
| Drug | verapamil | MYH1 MYH4 CYP3A7 MYH8 MYH10 MYH13 MYO5A ABCA13 MYH7B ATP8B1 ERLIN1 ATP2B2 TOP2B | 6.18e-05 | 490 | 165 | 13 | CID000002520 |
| Drug | AZ-A | 6.32e-05 | 58 | 165 | 5 | CID000451362 | |
| Drug | AC1NRBPQ | 6.46e-05 | 137 | 165 | 7 | CID005288569 | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 4.47e-11 | 13 | 164 | 6 | DOID:397 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 6.71e-10 | 80 | 164 | 9 | DOID:12930 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.23e-09 | 10 | 164 | 5 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.23e-09 | 10 | 164 | 5 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.23e-09 | 10 | 164 | 5 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.23e-09 | 10 | 164 | 5 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.23e-09 | 10 | 164 | 5 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.23e-09 | 10 | 164 | 5 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.23e-09 | 10 | 164 | 5 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.23e-09 | 10 | 164 | 5 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 3.83e-09 | 12 | 164 | 5 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 3.83e-09 | 12 | 164 | 5 | DOID:2106 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 1.43e-08 | 15 | 164 | 5 | DOID:0050646 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 7.04e-06 | 48 | 164 | 5 | DOID:423 (implicated_via_orthology) | |
| Disease | arylamine N-acetyltransferase 1 measurement | 3.07e-05 | 2 | 164 | 2 | EFO_0801394 | |
| Disease | sodium channel subunit beta-2 measurement | 3.07e-05 | 2 | 164 | 2 | EFO_0803085 | |
| Disease | B cell deficiency (implicated_via_orthology) | 3.07e-05 | 2 | 164 | 2 | DOID:2115 (implicated_via_orthology) | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 3.57e-05 | 12 | 164 | 3 | DOID:9119 (implicated_via_orthology) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 4.83e-05 | 71 | 164 | 5 | DOID:0050700 (implicated_via_orthology) | |
| Disease | birth weight, parental genotype effect measurement | 1.04e-04 | 192 | 164 | 7 | EFO_0004344, EFO_0005939 | |
| Disease | Familial dilated cardiomyopathy | 1.05e-04 | 44 | 164 | 4 | C0340427 | |
| Disease | abdominal fat cell number | 1.26e-04 | 198 | 164 | 7 | EFO_0021534 | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 1.83e-04 | 4 | 164 | 2 | cv:CN293514 | |
| Disease | Dyggve-Melchior-Clausen disease (implicated_via_orthology) | 1.83e-04 | 4 | 164 | 2 | DOID:0111167 (implicated_via_orthology) | |
| Disease | arthrogryposis multiplex congenita (is_implicated_in) | 1.83e-04 | 4 | 164 | 2 | DOID:0080954 (is_implicated_in) | |
| Disease | tyrosine-protein kinase TEC measurement | 1.83e-04 | 4 | 164 | 2 | EFO_0020830 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 3.04e-04 | 5 | 164 | 2 | C1450051 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 3.04e-04 | 5 | 164 | 2 | C0410190 | |
| Disease | Smith-McCort dysplasia (implicated_via_orthology) | 3.04e-04 | 5 | 164 | 2 | DOID:0060247 (implicated_via_orthology) | |
| Disease | single Ig IL-1-related receptor measurement | 3.04e-04 | 5 | 164 | 2 | EFO_0802072 | |
| Disease | ceramide measurement | 3.59e-04 | 235 | 164 | 7 | EFO_0010222 | |
| Disease | Emery-Dreifuss muscular dystrophy | 4.54e-04 | 6 | 164 | 2 | cv:C0410189 | |
| Disease | Bare Lymphocyte Syndrome | 4.54e-04 | 6 | 164 | 2 | C0242583 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 4.54e-04 | 6 | 164 | 2 | C0410189 | |
| Disease | response to angiotensin receptor blocker | 6.13e-04 | 30 | 164 | 3 | EFO_0010735 | |
| Disease | inter-alpha-trypsin inhibitor heavy chain H1 measurement | 6.33e-04 | 7 | 164 | 2 | EFO_0801705 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 6.33e-04 | 7 | 164 | 2 | C0751337 | |
| Disease | neonatal abstinence syndrome | 9.08e-04 | 77 | 164 | 4 | EFO_0005799 | |
| Disease | neuroimaging measurement | MYH10 ANK3 SPC25 REV3L ZHX2 BBS9 TFRC MRPL14 SND1 PDCD5 MACF1 PRKCSH SLC39A14 ARHGAP18 SETD3 | 9.57e-04 | 1069 | 164 | 15 | EFO_0004346 |
| Disease | Malignant neoplasm of breast | MYH1 XIRP1 KALRN CENPF SYNE1 ZNF318 ATP8B1 CHEK1 CLIP1 TFRC AKAP9 SYNE2 MACF1 DMD TOP2A | 1.00e-03 | 1074 | 164 | 15 | C0006142 |
| Disease | Primary ciliary dyskinesia | 1.05e-03 | 36 | 164 | 3 | cv:C0008780 | |
| Disease | Sclerocystic Ovaries | 1.29e-03 | 144 | 164 | 5 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 1.29e-03 | 144 | 164 | 5 | C0032460 | |
| Disease | Bardet-Biedl syndrome (implicated_via_orthology) | 1.63e-03 | 11 | 164 | 2 | DOID:1935 (implicated_via_orthology) | |
| Disease | unipolar depression, bipolar disorder | 1.83e-03 | 156 | 164 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | Renal dysplasia and retinal aplasia (disorder) | 1.95e-03 | 12 | 164 | 2 | C0403553 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 1.95e-03 | 12 | 164 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | Bardet-Biedl syndrome (is_implicated_in) | 2.67e-03 | 14 | 164 | 2 | DOID:1935 (is_implicated_in) | |
| Disease | Spastic Paraplegia, Hereditary | 2.67e-03 | 14 | 164 | 2 | C0037773 | |
| Disease | phosphatidylcholine 36:3 measurement | 3.07e-03 | 15 | 164 | 2 | EFO_0010381 | |
| Disease | Heschl's gyrus morphology measurement | 3.22e-03 | 53 | 164 | 3 | EFO_0005852 | |
| Disease | Antibody Deficiency Syndrome | 3.95e-03 | 17 | 164 | 2 | C0003257 | |
| Disease | neuroblastoma | 4.07e-03 | 116 | 164 | 4 | EFO_0000621 | |
| Disease | metabolite measurement | 4.24e-03 | 560 | 164 | 9 | EFO_0004725 | |
| Disease | open-angle glaucoma | 4.38e-03 | 191 | 164 | 5 | EFO_0004190 | |
| Disease | aspartate aminotransferase measurement | KALRN MYH7B SPC25 ATP8B1 ZAP70 ITIH1 ERLIN1 SND1 WDR11 HPR CD36 MYPN | 4.78e-03 | 904 | 164 | 12 | EFO_0004736 |
| Disease | Chronic myeloproliferative disorder | 4.93e-03 | 19 | 164 | 2 | C1292778 | |
| Disease | cystathionine measurement | 4.93e-03 | 19 | 164 | 2 | EFO_0010474 | |
| Disease | type 1 diabetes mellitus (biomarker_via_orthology) | 4.93e-03 | 19 | 164 | 2 | DOID:9744 (biomarker_via_orthology) | |
| Disease | Omenn Syndrome | 4.93e-03 | 19 | 164 | 2 | C2700553 | |
| Disease | factor VIII measurement, Ischemic stroke | 4.93e-03 | 19 | 164 | 2 | EFO_0004630, HP_0002140 | |
| Disease | testosterone measurement | CYP3A7 ANK3 MYO5A IQSEC2 ZNF318 ERLIN1 IQGAP1 ST3GAL5 WDR11 SYNE2 MYPN CEP70 MACF1 ATP2B2 CAP2 | 5.12e-03 | 1275 | 164 | 15 | EFO_0004908 |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 5.31e-03 | 200 | 164 | 5 | EFO_0004611, EFO_0020945 | |
| Disease | atherosclerosis (biomarker_via_orthology) | 5.46e-03 | 20 | 164 | 2 | DOID:1936 (biomarker_via_orthology) | |
| Disease | Severe Combined Immunodeficiency | 5.46e-03 | 20 | 164 | 2 | C0085110 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QKTGLKELEFLKKLN | 726 | Q13523 | |
| VAQKEILKLLKGKVV | 176 | Q8WTP8 | |
| GKVIKEITAKIQKLA | 581 | Q14264 | |
| LQKKIVNLQKIVEEK | 2536 | Q99996 | |
| KKLLELQKLLEGNEK | 2641 | Q99996 | |
| IKQLVEEIRKKTKII | 786 | Q7Z3E2 | |
| KILIKKQEFLEQKIQ | 31 | Q9BY43 | |
| LLSQEQIKQIKKDLK | 711 | P55884 | |
| TVKRLVKVKVLLKQD | 31 | P29374 | |
| QKAIKLEKKQKVVLG | 236 | Q6ZQR2 | |
| LGIANDQKVKIKKQE | 271 | Q9P2B7 | |
| LKIKGKLIDIVSSQK | 456 | O14757 | |
| IKLKNKKGLVSLIDL | 451 | Q96NH3 | |
| TVKLDELVKKIGKAV | 81 | O60239 | |
| KEIIKGIKILQNAII | 96 | Q9P0M2 | |
| ILEELLLKRSQQKKK | 6 | P51813 | |
| VFGKENKKKQLILKL | 321 | Q9NZN4 | |
| EKTKLLIAAQKQKVV | 191 | O75477 | |
| KRKQLVIKEKAILIS | 216 | Q9BYG8 | |
| GSIKQVALQIIEKLK | 1946 | Q86UQ4 | |
| GKEQQLKEKLEQVKL | 2241 | P11532 | |
| LEKLLKEKQALKSQI | 616 | Q8TEK3 | |
| KLTEELKKQIREKIG | 626 | Q9NR19 | |
| LEKLISGKIQEKVVK | 226 | Q9NSV4 | |
| DIIESKLKQVKKNGI | 1101 | Q9UKL3 | |
| KEKSVLQGKLTKLAV | 381 | Q01814 | |
| KQILEVIQKEGLKET | 31 | Q9C0F0 | |
| LNEILLEKKTKRNKI | 806 | O43520 | |
| RKKIIKETLLQLDQK | 181 | Q8IWF9 | |
| KVKQDLLELKSVIKL | 386 | Q9H095 | |
| KIGLLVKNKITLQDV | 916 | P46940 | |
| TLQEKKEKIQTGLKK | 1451 | P46940 | |
| KEKIQTGLKKLTELG | 1456 | P46940 | |
| KIRTVDIEGKKIKLQ | 46 | P51153 | |
| KIQTIELDGKTIKLQ | 46 | Q92928 | |
| QIGEKKLLVKVDAKT | 151 | P49756 | |
| KIRTIELDGKKIKLQ | 46 | Q92930 | |
| KVKEQSLENLIKGRK | 166 | Q9H2P9 | |
| EALLFEGIKKKKQQK | 511 | Q9UM07 | |
| KGVKLKKVQKDVLRE | 931 | Q8N9B5 | |
| VIQQSAAKKGVKIKL | 581 | P46199 | |
| QKVKQTKEALLKILG | 306 | P19827 | |
| VGELKLSKIQKNVKE | 426 | P19823 | |
| QKKLIELQAGKKSLE | 156 | P14314 | |
| QVDIGLIKLKQKVLV | 186 | P00739 | |
| NLATLKKKVVKEGEL | 1111 | Q96MR6 | |
| NDLLVVTKIFQKKKI | 1001 | Q5JU85 | |
| KKDLKQKLIIGISNS | 756 | Q5U5R9 | |
| IKGKVNSIIIDNCKK | 366 | P40123 | |
| LKLALQKLKQEEGKS | 546 | Q5JST6 | |
| SVAVKLGKTQKVKVL | 271 | Q9BT17 | |
| LLIKSKVQLEGKVKE | 956 | A7E2Y1 | |
| LIKNKIQLEAKIKEV | 911 | P13535 | |
| GLIEILKKVSQQTEK | 91 | O14737 | |
| VKTINEKLTIGKISK | 206 | A0PG75 | |
| AKQTKEKVKLLIQLA | 1181 | O60229 | |
| KTLQVEVKHLQQKLK | 311 | O95447 | |
| KSEIQLNVKELKRKL | 241 | Q8N9W4 | |
| QLIKTKIQLEAKIKE | 911 | P12882 | |
| KLQELIQKGTKLVLE | 496 | O00410 | |
| IKLIQADILKNKLSK | 36 | P20783 | |
| IVKGLEQDKEVLKKQ | 1591 | O95613 | |
| KQQKIEIRKDTLKTL | 251 | P63135 | |
| KELQKIIKDVNKSQG | 386 | Q3SYG4 | |
| VQVKKTLGIKLELKS | 2206 | Q9UPN3 | |
| TKLLIAAQKQKVVEK | 191 | O94905 | |
| IKKKDEKIQLLELQL | 731 | Q9H7U1 | |
| ILIGQKKLELKTAKN | 2816 | Q9P2D7 | |
| KKKQIEALQGELKIA | 971 | Q15075 | |
| KLIITLGKKQKRKNE | 596 | Q3L8U1 | |
| QENLGKKLREKQKVI | 611 | Q8WYA0 | |
| KEKQKKLVEQLTGLI | 46 | Q9P2D3 | |
| SGKKQIEKLEQELKR | 106 | P49454 | |
| LEKALKKNVKLQELI | 306 | Q8NHQ1 | |
| LKFLQKVEAGKVAIK | 46 | Q9BPX7 | |
| IKSNIRLGKLEEKVK | 641 | Q96ST8 | |
| DLLIQKTIKKQVVLE | 31 | P16671 | |
| LIKNLKNEITKKVQV | 436 | P53621 | |
| QKLKEVISLEKLNVG | 176 | Q9H2C0 | |
| VKLKVEQKLEQIGKV | 966 | Q5TH69 | |
| LKGLEDTKLVQVVLK | 391 | Q12934 | |
| VAKQTKGKIVDLLKN | 176 | P05154 | |
| FDILLGLDVNKKVKK | 231 | Q96P44 | |
| QKTKELIGIRQKSKL | 3851 | Q12955 | |
| LSKLQGEQKKINKIE | 61 | B2RV13 | |
| KLEAEKKKLRTILQV | 206 | Q6IMN6 | |
| KIHELEKQGTIKIQK | 471 | Q96PY5 | |
| LKEFILNNEGKLKKL | 926 | Q96PY5 | |
| VKTEGERKEIKQKQL | 446 | Q6ZN28 | |
| GLNLTEKIKKIKIVF | 341 | Q14767 | |
| DVTGTIAQVKQKIKK | 246 | P10911 | |
| IKNKKKLLITGTEQF | 696 | Q92538 | |
| EKKEINKRKQLILEG | 406 | Q9Y6V7 | |
| TELTGLKDVIKKNKQ | 516 | A6NGE4 | |
| LQIDLNKEKKITGII | 351 | Q96PD2 | |
| KSVKQIKEGRLKETQ | 251 | P24462 | |
| LKANEIIKKLQGDLK | 381 | Q6UVJ0 | |
| FTEKILKILLKQKNE | 236 | Q15043 | |
| LLKVLQEQLKGTKEL | 511 | Q8TC92 | |
| LAVNIIAKKIVLKEQ | 286 | P11926 | |
| LLKVKEKQTKVEGEL | 861 | P35580 | |
| VKLELKVKNLELQLK | 1281 | P30622 | |
| VETLVNLVKKKGSKQ | 266 | Q03701 | |
| KKGKKIDLETILLLN | 66 | Q8N4N8 | |
| LTFKKGEILLVIEKK | 171 | O15259 | |
| EKLGLKKLVLTQEQK | 1436 | O94851 | |
| ISKLQIRTIKKGDKE | 256 | Q9ULK6 | |
| EIKKENGEVKILLKS | 221 | Q6PCB5 | |
| IQLVLKQKETISKKE | 1231 | Q6WKZ4 | |
| IVKKEFVKENLVKLL | 91 | O75674 | |
| VDQVVGKLIEVVKKK | 351 | Q02880 | |
| KKELKELIQKELTIG | 31 | P06703 | |
| LKQKILKVTEQIKIE | 71 | Q9ULS5 | |
| DQILLAIKGQKKKAL | 71 | Q6P1L8 | |
| VKTNGKLVKQELKDR | 5311 | Q8NF91 | |
| QTIELQIKKLKELQK | 8476 | Q8NF91 | |
| KGKLSDNILKLEKQI | 946 | Q8WXH0 | |
| ILEEILIKRSQQKKK | 6 | P42680 | |
| ILKQDHQILGKKIKR | 421 | Q15573 | |
| KKTVVSVKKLLQDLG | 141 | Q15572 | |
| EGSLQKAEKVLKKVL | 291 | Q96NG3 | |
| LQEIKKFIKGVSEKI | 966 | O14802 | |
| LVEKIRKKQKGLSVT | 56 | Q86TU7 | |
| KFLLKLVKEGVVKDL | 396 | Q9UNP4 | |
| LKKVKSILNIVKEGQ | 316 | Q9Y6H5 | |
| LRKKLIGKKVNVTVD | 406 | Q7KZF4 | |
| QLIKTKIQLEAKIKE | 911 | Q9Y623 | |
| IQRNVQKLKDTVKKL | 141 | Q9GZX6 | |
| KEAEKIIKNLIKTVI | 66 | O95379 | |
| VKVKVLKQKDSLLQA | 121 | Q5PT55 | |
| VSKQTKALIDKLQKL | 1151 | Q13972 | |
| KNVKLTVSNVLKEIK | 371 | P02786 | |
| KLLTKQAGEIKTLKE | 161 | Q86YF9 | |
| NLLKLIAEVKGKKQE | 81 | Q9HBM1 | |
| VKVLEIKNKARKLNI | 46 | A8MXE2 | |
| ALEKIKIQLEKGNKE | 886 | Q9BPX3 | |
| KKKVVILNVDLLKLE | 891 | Q14690 | |
| KKQIDVAIKVLKQGT | 361 | P43403 | |
| LVKLGKIDSKEKQVI | 991 | O60673 | |
| KNKIENKIESIGLKR | 146 | O60831 | |
| RIIKNEVKKLQKAAL | 121 | P50914 | |
| KLNKINTLKETIQKG | 831 | Q8NDV3 | |
| VKEIKVLQKIGKDTF | 151 | P49675 | |
| VQLLELGKKKKQILH | 601 | O75717 | |
| LKNTVKISKREGKEL | 356 | Q9BX26 | |
| LSLKEGDIIKILNKK | 801 | P15498 | |
| VLKLLNKNGTVKKVS | 1026 | Q9H0E3 | |
| QLEQQVEKLRKKLKT | 151 | Q9NVV9 | |
| SKVTINNKVILLKKE | 816 | Q8TEQ6 | |
| KVGENEIIAKKLKIE | 136 | Q9BTF0 | |
| GLIKSKILLEAKVKE | 911 | Q9UKX3 | |
| KKKVKIIQGDIIASN | 481 | Q8WWQ8 | |
| KQGQIERVIKEKKAV | 411 | Q96NL6 | |
| VIILQGSKSVELKKK | 161 | Q495X7 | |
| VLGIELKQQKAVKIK | 301 | Q8N392 | |
| GIIKATEEQKKKTIV | 411 | Q8IUH5 | |
| KEIIALKSNIVELKK | 811 | Q9BZF9 | |
| ENKPKKELIKVLIQR | 1066 | P11388 | |
| QKFKEKTQGQVKILE | 531 | Q9Y6X8 | |
| KQAIKILIKASEIAK | 251 | Q8NA56 | |
| LHKKKLQQGILVKCI | 601 | Q13342 | |
| VQLKEIIKILEKLNG | 2296 | Q5VWN6 | |
| VSNKEQKLEKKILKG | 126 | Q8N3L3 | |
| VEAKKFGVSIQLKKL | 401 | Q3SY77 | |
| EAGVIETIKNKIKKN | 101 | Q8N584 | |
| AKKALNKVKILITQE | 221 | Q9BZH6 | |
| LDKGKIIKQQETVII | 186 | Q5VZ18 | |
| EETQVILKKGKKVIF | 1361 | Q6ZQQ6 | |
| IQELKGDVKKTVKLF | 221 | Q702N8 | |
| RNTGIKLQLKEEVKK | 1251 | Q5VUA4 | |
| LLENIILKTSGQKIK | 916 | Q9NYU2 | |
| KVKLKLLKEQIQEPV | 96 | A8MT70 | |
| KQLKVFAKKIGELEV | 1431 | Q9Y4I1 | |
| KEVKKAPVILEKLQN | 1166 | Q86TC9 |